Browse by UCL Departments and Centres
![[up]](/style/images/multi_up.png)
Up a levelGroup by: Author | Type
Number of items: 456.
Article
Aad, G;
Abbott, B;
Abbott, DC;
Abdinov, O;
Abud, AA;
Abeling, K;
Abhayasinghe, DK;
... Pereira, RA; + view all
(2020)
Search for electroweak production of charginos and sleptons decaying into final states with two leptons and missing transverse momentum in √s=13 TeV pp collisions using the ATLAS detector.
European Physical Journal C
, 80
, Article 123. 10.1140/epjc/s10052-019-7594-6.
|
 |
|
Abbas, A;
Tabish, TA;
Bull, SJ;
Lim, TM;
Phan, AN;
(2020)
High yield synthesis of graphene quantum dots from biomass waste as a highly selective probe for Fe3+ sensing.
Scientific Reports
, 10
, Article 21262. 10.1038/s41598-020-78070-2.
|
|
|
AbdulJabbar, K;
Raza, SEA;
Rosenthal, R;
Jamal-Hanjani, M;
Veeriah, S;
Akarca, A;
Lund, T;
... Yuan, Y; + view all
(2020)
Geospatial immune variability illuminates differential evolution of lung adenocarcinoma.
Nature Medicine
, 26
pp. 1054-1062.
10.1038/s41591-020-0900-x.
|
|
Abou-Alfa, GK;
Macarulla, T;
Javle, MM;
Kelley, RK;
Lubner, SJ;
Adeva, J;
Cleary, JM;
... Zhu, AX; + view all
(2020)
Ivosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study.
The Lancet Oncology
, 21
(6)
pp. 796-807.
10.1016/S1470-2045(20)30157-1.
|
|
Agbuduwe, C;
Yang, H;
Gaglani, J;
Ajithkumar, T;
(2020)
Clinical presentation and outcomes of solitary plasmacytoma in a tertiary hospital in the UK.
Clinical Medicine Journal
, 20
(5)
e191-e195.
10.7861/clinmed.2019-0488.
|
|
Agbuduwe, C;
Basu, S;
(2020)
Hematolological Manifestations of COVID-19: From Cytopenia to Coagulopathy.
European Journal of Haematology
10.1111/ejh.13491.
(In press).
|
|
|
Ahern, A;
Griffin, S;
Wheeler, G;
Sharp, S;
Aveyard, P;
Boyland, E;
Halford, J;
(2020)
The effect of referral to an open-group behavioural weight management programme on the relative risk of normoglycaemia, non-diabetic hyperglycaemia and type 2 diabetes: secondary analysis of the WRAP trial.
Diabetes, Obesity and Metabolism
, 22
(11)
pp. 2069-2076.
10.1111/dom.14123.
|
|
|
Ahmed, J;
Tabish, TA;
Zhang, S;
Edirisinghe, M;
(2020)
Porous Graphene Composite Polymer Fibres.
Polymers
, 13
(1)
, Article 76. 10.3390/polym13010076.
|
|
|
Ainley, L;
Law, S;
Heptinstall, L;
Rodriguez-Justo, M;
Thomson, K;
Pepper, RJ;
(2020)
Treatment of concurrent minimal change disease and Epstein Barr virus driven post-transplant lymphoproliferative disorder with Rituximab following haematopoietic stem cell transplantation.
Kidney International Reports
10.1016/j.ekir.2020.10.012.
(In press).
|
|
Aitken, J;
Ambrose, K;
Barrell, S;
Beale, R;
Bineva-Todd, G;
Biswas, D;
Byrne, R;
... Wu, M; + view all
(2020)
Scalable and robust SARS-CoV-2 testing in an academic center.
Nature Biotechnology
, 38
(8)
pp. 927-931.
10.1038/s41587-020-0588-y.
|
|
|
Ali, A;
Plus 12 other authors, TPUWPO;
Sydes, M;
Clarke, NW;
(2020)
The Automated Bone Scan Index as a Predictor of Response to Prostate Radiotherapy in Men with Newly Diagnosed Metastatic Prostate Cancer: An Exploratory Analysis of STAMPEDE’s “M1|RT Comparison”.
European Urology Oncology
, 3
(4)
pp. 412-419.
10.1016/j.euo.2020.05.003.
|
|
|
Ali, H;
Puccio, I;
Akarca, AU;
Bob, R;
Pomplun, S;
Keong Wong, W;
Gupta, R;
... Marafioti, T; + view all
(2020)
Megakaryocytes, erythropoietic and granulopoietic cells express CAL2 antibody in myeloproliferative neoplasms carrying CALR gene mutations.
International Journal of Experimental Pathology
10.1111/iep.12375.
|
|
|
Almarzouki, A;
Wilson, D;
Ambler, G;
Shakeshaft, C;
Cohen, H;
Yousry, T;
Salman, RA-S;
... Werring, DJ; + view all
(2020)
Sensitivity and specifcity of blood‑fuid levels for oral anticoagulant‑associated intracerebral haemorrhage.
Scientific Reports
, 10
(1)
, Article 15529. 10.1038/s41598-020-72504-7.
|
|
|
Alrasheed, N;
Lee, L;
Ghorani, E;
Henry, JY;
Conde, L;
Chin, M;
Galas-Filipowicz, D;
... Yong, KL; + view all
(2020)
Marrow-Infiltrating Regulatory T Cells Correlate with the Presence of Dysfunctional CD4⁺PD-1⁺ Cells and Inferior Survival in Patients with Newly Diagnosed Multiple Myeloma.
Clinical Cancer Research
, 26
(13)
pp. 3443-3454.
10.1158/1078-0432.CCR-19-1714.
|
|
Alwan, NA;
Burgess, RA;
Ashworth, S;
Beale, R;
Bhadelia, N;
Bogaert, D;
Dowd, J;
... Ziauddeen, H; + view all
(2020)
Scientific consensus on the COVID-19 pandemic: we need to act now.
The Lancet
, 396
(10260)
e71-e72.
10.1016/S0140-6736(20)32153-X.
|
|
|
Amir, A;
Porwal, H;
Mahalingam, S;
Wu, X;
Wu, T;
Chen, B;
Tabish, TA;
(2020)
Microstructure of fibres pressure-spun from polyacrylonitrile – graphene oxide composite mixtures.
Composites Science and Technology
, 197
, Article 108214. 10.1016/j.compscitech.2020.108214.
|
|
An, Z;
Flores-Borja, F;
Irshad, S;
Deng, J;
Ng, T;
(2020)
Pleiotropic Role and Bidirectional Immunomodulation of Innate Lymphoid Cells in Cancer.
Frontiers in Immunology
, 10
, Article 3111. 10.3389/fimmu.2019.03111.
|
|
|
Anandagoda, N;
Roberts, L;
Willis, JCD;
Sarathchandra, P;
Xiao, F;
Jackson, I;
Hertweck, A;
... Lord, GM; + view all
(2020)
Dominant regulation of long-term allograft survival is mediated by microRNA-142.
American Journal of Transplantation
, 20
(10)
pp. 2715-2727.
10.1111/ajt.15907.
|
|
Anderton, J;
Moroz, V;
Marec-Bérard, P;
Gaspar, N;
Laurence, V;
Martín-Broto, J;
Sastre, A;
... Brennan, B; + view all
(2020)
International randomised controlled trial for the treatment of newly diagnosed EWING sarcoma family of tumours - EURO EWING 2012 Protocol.
Trials
, 21
(1)
, Article 96. 10.1186/s13063-019-4026-8.
|
|
|
Angelis, A;
Naci, H;
Hackshaw, A;
(2020)
Recalibrating Health Technology Assessment Methods for Cell and Gene Therapies.
Pharmacoeconomics
, 38
pp. 1297-1308.
10.1007/s40273-020-00956-w.
|
|
Annibaldi, A;
Walczak, H;
(2020)
Death Receptors and Their Ligands in Inflammatory Disease and Cancer.
Cold Spring Harbor Perspectives in Biology
10.1101/cshperspect.a036384.
(In press).
|
|
|
Aref, S;
Castleton, AZ;
Bailey, K;
Burt, R;
Dey, A;
Leongamornlert, D;
Mitchell, RJ;
... Fielding, AK; + view all
(2020)
Type-1 Interferon Responses Underlie Tumor-Selective Replication of Oncolytic Measles Virus.
Molecular Therapy
, 28
(4)
pp. 1043-1055.
10.1016/j.ymthe.2020.01.027.
|
|
Argiles, G;
Tabernero, J;
Labianca, R;
Hochhauser, D;
Salazar, R;
Iveson, T;
Laurent-Puig, P;
... ESMO Guidelines Committee; + view all
(2020)
Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Annals of Oncology
, 31
(10)
pp. 1291-1305.
10.1016/j.annonc.2020.06.022.
|
|
Ascierto, PA;
Bifulco, C;
Galon, J;
Garbe, C;
Khleif, SN;
McQuade, J;
Odunsi, K;
... Puzanov, I; + view all
(2020)
The Great Debate at 'Immunotherapy Bridge', Naples, December 5, 2019.
Journal for ImmunoTherapy of Cancer
, 8
(2)
, Article e000921. 10.1136/jitc-2020-000921.
|
|
|
Atkin, C;
Iqbal, G;
Planche, T;
Pratt, G;
Yong, K;
Wood, J;
Raynes, K;
... Trial Investigators; + view all
(2020)
Diagnostic pathways in multiple myeloma and their relationship to end organ damage: an analysis from the Tackling Early Morbidity and Mortality in Myeloma (TEAMM) trial.
British Journal of Haematology
10.1111/bjh.17044.
(In press).
|
|
|
Augusto, JB;
Johner, N;
Shah, D;
Nordin, S;
Knott, KD;
Rosmini, S;
Lau, C;
... Namdar, M; + view all
(2020)
The myocardial phenotype of Fabry disease pre-hypertrophy and pre-detectable storage.
European Heart Journal: Cardiovascular Imaging
10.1093/ehjci/jeaa101.
(In press).
|
|
|
Augusto, JB;
Nordin, S;
Vijapurapu, R;
Baig, S;
Bulluck, H;
Castelletti, S;
Alfarih, M;
... Moon, JC; + view all
(2020)
Myocardial Edema, Myocyte Injury, and Disease Severity in Fabry Disease.
Circulation: Cardiovascular Imaging
, 13
(3)
, Article e010171. 10.1161/CIRCIMAGING.119.010171.
|
|
|
Awan, M;
Buriak, I;
Fleck, R;
Fuller, B;
Goltsev, A;
Kerby, J;
Lowdell, M;
... Stacey, GN; + view all
(2020)
Dimethyl sulfoxide: a central player since the dawn of cryobiology, is efficacy balanced by toxicity?
Regenerative Medicine
, 15
(3)
10.2217/rme-2019-0145.
|
|
|
Azad, AK;
Zhabyeyev, P;
Vanhaesebroeck, B;
Eitzen, G;
Oudit, GY;
Moore, RB;
Murray, AG;
(2020)
Inactivation of endothelial cell phosphoinositide 3-kinase β inhibits tumor angiogenesis and tumor growth.
Oncogene
, 39
pp. 6480-6492.
10.1038/s41388-020-01444-3.
|
|
Bahleda, R;
Meric-Bernstam, F;
Goyal, L;
Tran, B;
He, Y;
Yamamiya, I;
Benhadji, KA;
... Arkenau, H-T; + view all
(2020)
Phase I, first-in-human study of futibatinib, a highly selective, irreversible FGFR1-4 inhibitor in patients with advanced solid tumors.
Annals of Oncology
10.1016/j.annonc.2020.06.018.
(In press).
|
|
|
Bailey, C;
Black, JRM;
Swanton, C;
(2020)
Cancer Research: The Lessons to Learn from COVID-19.
Cancer Discovery
, 10
(9)
pp. 1263-1266.
10.1158/2159-8290.CD-20-0823.
|
|
Bailey, C;
Shoura, MJ;
Mischel, PS;
Swanton, C;
(2020)
Extrachromosomal DNA d relieving heredity constraints, accelerating tumour evolution.
Annals of Oncology
, 31
(7)
pp. 884-893.
10.1016/j.annonc.2020.03.303.
|
|
Balogh, E;
Chandler, J;
Varga, M;
Tahoun, M;
Menyhárd, DK;
Schay, G;
Goncalves, T;
... Tory, K; + view all
(2020)
Pseudouridylation defect due to DKC1 and NOP10 mutations causes nephrotic syndrome with cataracts, hearing impairment, and enterocolitis.
Proceedings of the National Academy of Sciences of the United States of America
, 117
(26)
pp. 15137-15147.
10.1073/pnas.2002328117.
|
|
Balogh, P;
O'Donnell, P;
Lindsay, D;
Amary, MF;
Flanagan, AM;
Tirabosco, R;
(2020)
Extra‐axial Skeletal Poorly Differentiated Chordoma. A Case Report.
Histopathology
, 76
(6)
pp. 924-927.
10.1111/his.14056.
|
|
Banales, JM;
Marin, JJG;
Lamarca, A;
Rodrigues, PM;
Khan, SA;
Roberts, LR;
Cardinale, V;
... Gores, GJ; + view all
(2020)
Cholangiocarcinoma 2020: the next horizon in mechanisms and management.
Nature Reviews Gastroenterology & Hepatology
10.1038/s41575-020-0310-z.
(In press).
|
|
|
Banerjee, G;
Ambler, G;
Wilson, D;
Hostettler, IC;
Shakeshaft, C;
Lunawat, S;
Cohen, H;
... CROMIS-2 collaborators, .; + view all
(2020)
Baseline factors associated with early and late death in intracerebral haemorrhage survivors.
European Journal of Neurology
, 27
(7)
pp. 1257-1263.
10.1111/ene.14238.
|
|
|
Banerjee, G;
Chan, E;
Ambler, G;
Wilson, D;
Cipolotti, L;
Shakeshaft, C;
Cohen, H;
... CROMIS‐2 Collaborators, *; + view all
(2020)
Cognitive Impairment Before Atrial Fibrillation-Related Ischemic Events: Neuroimaging and Prognostic Associations.
Journal of the American Heart Association
, 9
(1)
, Article e014537. 10.1161/JAHA.119.014537.
|
|
|
Banerjee, G;
Wilson, D;
Ambler, G;
Hostettler, IC;
Shakeshaft, C;
Cohen, H;
Yousry, T;
... CROMIS-2 collaborators; + view all
(2020)
Longer term stroke risk in intracerebral haemorrhage survivors.
Journal of Neurology, Neurosurgery and Psychiatry
10.1136/jnnp-2020-323079.
(In press).
|
|
|
Banerjee, S;
Tovey, H;
Bowen, R;
Folkerd, E;
Kilburn, L;
McLachlan, J;
Hall, M;
... Bliss, JM; + view all
(2020)
Abiraterone in patients with recurrent epithelial ovarian cancer: principal results of the phase II Cancer of the Ovary Abiraterone (CORAL) trial (CRUK-A16037).
Therapeutic Advances in Medical Oncology
, 12
, Article ARTN 175. 10.1177/1758835920975352.
|
|
|
Banerjee, SM;
El-Sheikh, S;
Malhotra, A;
Mosse, CA;
Parker, S;
Williams, NR;
MacRobert, AJ;
... Keshtgar, MR; + view all
(2020)
Photodynamic Therapy in Primary Breast Cancer.
Journal of Clinical Medicine
, 9
(2)
, Article 483. 10.3390/jcm9020483.
|
|
|
Barry, A;
Apisarnthanarax, S;
O'Kane, GM;
Sapisochin, G;
Beecroft, R;
Salem, R;
Yoon, SM;
... Hawkins, MA; + view all
(2020)
Management of primary hepatic malignancies during the COVID-19 pandemic: recommendations for risk mitigation from a multidisciplinary perspective.
The Lancet Gastroenterology & Hepatology
10.1016/S2468-1253(20)30182-5.
(In press).
|
|
Bartlett, JMS;
Bayani, J;
Kornaga, EN;
Danaher, P;
Crozier, C;
Piper, T;
Yao, CQ;
... Stein, RC; + view all
(2020)
Computational approaches to support comparative analysis of multiparametric tests: Modelling versus Training.
PLOS ONE
, 15
(9)
, Article e0238593. 10.1371/journal.pone.0238593.
|
|
|
Bekaii-Saab, TS;
Valle, JW;
Cutsem, EV;
Rimassa, L;
Furuse, J;
Ioka, T;
Melisi, D;
... Vogel, A; + view all
(2020)
FIGHT-302: first-line pemigatinib vs gemcitabine plus cisplatin for advanced cholangiocarcinoma with FGFR2 rearrangements.
Future Oncology
10.2217/fon-2020-0429.
(In press).
|
|
|
Bell, R;
Kirkwood, A;
Hargrave, D;
Michalski, A;
Hyare, H;
Jacques, T;
Stoneham, S;
... Shankar, A; + view all
(2020)
Disseminated Low Grade Glioma in Children and Young Adults.
ARC Journal of Cancer Science
, 6
(1)
pp. 7-18.
10.20431/2455-6009.0601002.
|
|
Berry, V;
Ionides, A;
Pontikos, N;
Moghul, I;
Moore, AT;
Quinlan, RA;
Michaelides, M;
(2020)
Whole Exome Sequencing Reveals Novel and Recurrent Disease-Causing Variants in Lens Specific Gap Junctional Protein Encoding Genes Causing Congenital Cataract.
Genes
, 11
(5)
, Article 512. 10.3390/genes11050512.
|
|
|
Bertaux, F;
von Kugelgen, J;
Marguerat, S;
Shahrezaei, V;
(2020)
A bacterial size law revealed by a coarse-grained model of cell physiology.
PLOS Computational Biology
, 16
(9)
10.1371/journal.pcbi.1008245.
|
|
|
Best, JG;
Barbato, C;
Ambler, G;
Du, H;
Banerjee, G;
Wilson, D;
Shakeshaft, C;
... Clinical Relevance of Microbleeds in Stroke (CROMIS-2) collabora; + view all
(2020)
Association of enlarged perivascular spaces and anticoagulant-related intracranial hemorrhage.
Neurology
10.1212/WNL.0000000000010788.
(In press).
|
|
|
Beyrouti, R;
Adams, ME;
Benjamin, L;
Cohen, H;
Farmer, SF;
Goh, YY;
Humphries, F;
... Werring, DJ; + view all
(2020)
Characteristics of ischaemic stroke associated with COVID-19.
[Letter].
Journal of Neurology, Neurosurgery and Psychiatry
10.1136/jnnp-2020-323586.
(In press).
|
|
|
Bhatnagar, G;
Rodriguez-Justo, M;
Higginson, A;
Bassett, P;
Windsor, A;
Cohen, R;
Halligan, S;
(2020)
Inflammation and fibrosis in Crohn's disease: location-matched histological correlation of small bowel ultrasound features.
Abdominal Radiology
10.1007/s00261-020-02603-6.
(In press).
|
|
|
Birkbak, NJ;
McGranahan, N;
(2020)
Cancer Genome Evolutionary Trajectories in Metastasis.
Cancer Cell
, 37
(1)
pp. 8-19.
10.1016/j.ccell.2019.12.004.
|
|
Bishton, MJ;
Rule, S;
Wilson, W;
Turner, D;
Patmore, R;
Clifton-Hadley, L;
McMillan, A;
... Haynes, A; + view all
(2020)
The UK NCRI study of chlorambucil, mitoxantrone and dexamethasone (CMD) versus fludarabine, mitoxantrone and dexamethasone (FMD) for untreated advanced stage follicular lymphoma: molecular response strongly predicts prolonged overall survival.
British Journal of Haematology
, 190
(4)
pp. 545-554.
10.1111/bjh.16555.
|
|
Black, JRM;
Bailey, C;
Przewrocka, J;
Dijkstra, KK;
Swanton, C;
(2020)
COVID-19: the case for health-care worker screening to prevent hospital transmission.
The Lancet
, 395
(10234)
pp. 1418-1420.
10.1016/S0140-6736(20)30917-X.
|
|
|
Blagden, SP;
Cook, AD;
Poole, C;
Howells, L;
McNeish, IA;
Dean, A;
Kim, J-W;
... Clamp, AR; + view all
(2020)
Weekly platinum-based chemotherapy versus 3-weekly platinum-based chemotherapy for newly diagnosed ovarian cancer (ICON8): quality-of-life results of a phase 3, randomised, controlled trial.
The Lancet Oncology
, 21
(7)
pp. 969-977.
10.1016/S1470-2045(20)30218-7.
|
|
|
Blagih, J;
Zani, F;
Chakravarty, P;
Hennequart, M;
Pilley, S;
Hobor, S;
Hock, AK;
... Vousden, KH; + view all
(2020)
Cancer-Specific Loss of p53 Leads to a Modulation of Myeloid and T Cell Responses.
Cell Reports
, 30
(2)
481-496.e6.
10.1016/j.celrep.2019.12.028.
|
|
|
Bono, P;
Massard, C;
Peltola, KJ;
Azaro, A;
Italiano, A;
Kristeleit, RS;
Curigliano, G;
... Rodon, JA; + view all
(2020)
Phase I/IIa, open-label, multicentre study to evaluate the optimal dosing and safety of ODM-203 in patients with advanced or metastatic solid tumours.
ESMO Open
, 5
(6)
, Article e001081. 10.1136/esmoopen-2020-001081.
|
|
|
Booth, S;
Plaschkes, H;
Kirkwood, AA;
Gibb, A;
Horgan, P;
Higham, C;
Oladipo, JM;
... Eyre, TA; + view all
(2020)
Fractures are common within 18 months following first-line R-CHOP in older patients with diffuse large B-cell lymphoma.
Blood Advances
, 4
(18)
pp. 4337-4346.
10.1182/bloodadvances.2020002553.
|
|
|
Bray, T;
Sakai, N;
Dudek, A;
Fisher, C;
Rajesparan, K;
Lopes, A;
Ciurtin, C;
... Hall-Craggs, M; + view all
(2020)
Histographic Analysis of Oedema and Fat in Inflamed Bone Marrow based on Quantitative MRI.
European Radiology
, 313
10.1007/s00330-020-06785-x.
|
|
|
Brazil, L;
Swampillai, AL;
Mak, KM;
Edwards, D;
Mesiri, P;
Clifton-Hadley, L;
Shaffer, R;
... Short, SC; + view all
(2020)
Hydroxychloroquine and short-course radiotherapy in elderly patients with newly diagnosed high-grade glioma: a randomized phase II trial.
Neuro-Oncology Advances
, 2
(1)
10.1093/noajnl/vdaa046.
|
|
|
Bridgewater, JA;
Pugh, SA;
Maishman, T;
Eminton, Z;
Mellor, J;
Whitehead, A;
Stanton, L;
... New EPOC investigators; + view all
(2020)
Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis (New EPOC): long-term results of a multicentre, randomised, controlled, phase 3 trial.
The Lancet Oncology
, 21
(3)
pp. 398-411.
10.1016/S1470-2045(19)30798-3.
|
|
|
Brocklebank, V;
Kumar, G;
Howie, AJ;
Chandar, J;
Milford, DV;
Craze, J;
Evans, J;
... Kavanagh, D; + view all
(2020)
Long-term outcomes and response to treatment in diacylglycerol kinase epsilon nephropathy.
Kidney International
, 97
(6)
pp. 1260-1274.
10.1016/j.kint.2020.01.045.
|
|
|
Bultitude, WP;
Schellekens, J;
Szydlo, RM;
Anthias, C;
Cooley, SA;
Miller, JS;
Weisdorf, DJ;
... Marsh, SGE; + view all
(2020)
Presence of donor-encoded centromeric KIR B content increases the risk of infectious mortality in recipients of myeloablative, T-cell deplete, HLA-matched HCT to treat AML.
Bone Marrow Transplantation
, 55
pp. 1975-1984.
10.1038/s41409-020-0858-9.
|
|
Burnett, T;
Mozgunov, P;
Pallmann, P;
Villar, SS;
Wheeler, GM;
Jaki, T;
(2020)
Adding flexibility to clinical trial designs: an example-based guide to the practical use of adaptive designs.
BMC Medicine
, 18
, Article 352. 10.1186/s12916-020-01808-2.
|
|
|
Bustoros, M;
Sklavenitis-Pistofidis, R;
Park, J;
Redd, R;
Zhitomirsky, B;
Dunford, AJ;
Salem, K;
... Ghobrial, IM; + view all
(2020)
Genomic Profiling of Smoldering Multiple Myeloma Identifies Patients at a High Risk of Disease Progression.
Journal of Clinical Oncology
, 38
(21)
pp. 2380-2389.
10.1200/JCO.20.00437.
|
|
Cappellini, MD;
Viprakasit, V;
Taher, AT;
Georgiev, P;
Kuo, KHM;
Coates, T;
Voskaridou, E;
... BELIEVE Investigators; + view all
(2020)
A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-Thalassemia.
The New England Journal of Medicine
, 382
(13)
pp. 1219-1231.
10.1056/NEJMoa1910182.
|
|
Caravagna, G;
Heide, T;
Williams, MJ;
Zapata, L;
Nichol, D;
Chkhaidze, K;
Cross, W;
... Sottoriva, A; + view all
(2020)
Subclonal reconstruction of tumors by using machine learning and population genetics.
Nature Genetics
, 52
(9)
pp. 898-907.
10.1038/s41588-020-0675-5.
|
|
Carmona Echeverria, LM;
Haider, A;
Freeman, A;
Stopka-Farooqui, U;
Rosenfeld, A;
Simpson, BS;
Hu, Y;
... Whitaker, HC; + view all
(2020)
A critical evaluation of visual proportion of Gleason 4 and maximum cancer core length quantified by histopathologists.
Scientific Reports
, 10
, Article 17177. 10.1038/s41598-020-73524-z.
|
|
|
Carter, TJ;
Milic, M;
McDerra, J;
McTiernan, A;
Ahmed, M;
Karavasilis, V;
Michelagnoli, M;
... Strauss, SJ; + view all
(2020)
Continuous 14 Day Infusional Ifosfamide for Management of Soft-Tissue and Bone Sarcoma: A Single Centre Retrospective Cohort Analysis.
Cancers
, 12
(11)
, Article 3408. 10.3390/cancers12113408.
|
|
|
Casiraghi, N;
Orlando, F;
Ciani, Y;
Xiang, J;
Sboner, A;
Elemento, O;
Attard, G;
... Romanel, A; + view all
(2020)
ABEMUS: platform specific and data informed detection of somatic SNVs in cfDNA.
Bioinformatics
, 36
(9)
pp. 2665-2674.
10.1093/bioinformatics/btaa016.
|
|
Chalmers, AJ;
Chan, C;
Sebag-Montefiore, D;
Sebag-Montefiore, D;
Evans, M;
Chalmers, A;
McKenna, G;
... Chan, C; + view all
(2020)
CTRad 10 Years On: From 10-point Plan to Top 10 Achievements.
Clinical Oncology
, 32
(1)
pp. 9-12.
10.1016/j.clon.2019.09.043.
|
|
Chambers, P;
Man, KKC;
Lui, VWY;
Mpima, S;
Nasuti, P;
Forster, MD;
Wong, ICK;
(2020)
Understanding Molecular Testing Uptake Across Tumor Types in Eight Countries: Results From a Multinational Cross-Sectional Survey.
JCO Precision Oncology
, 16
(8)
e770-e778.
10.1200/JOP.19.00507.
|
|
Chandy, ETJ;
Saxby, HJ;
Pang, JW;
Sharma, RA;
(2020)
The multidisciplinary management of oligometastases from colorectal cancer: a narrative review.
Annals of Palliative Medicine
10.21037/apm-20-919.
(In press).
|
|
|
Chari, A;
Samur, MK;
Martinez-Lopez, J;
Cook, G;
Biran, N;
Yong, KL;
Hungria, VTDM;
... Avet-Loiseau, H; + view all
(2020)
Clinical features associated with COVID-19 outcome in multiple myeloma: first results from the International Myeloma Society data set.
Blood
, 136
(26)
pp. 3033-3040.
10.1182/blood.2020008150.
|
|
Chau, I;
Penel, N;
Soriano, AO;
Arkenau, HT;
Cultrera, J;
Santana-Davila, R;
Calvo, E;
... Fuchs, CS; + view all
(2020)
Ramucirumab in combination with pembrolizumab in treatment-naïve advanced gastric or gej adenocarcinoma: Safety and antitumor activity from the phase 1a/b jvdf trial.
Cancers
, 12
(10)
, Article 2985. 10.3390/cancers12102985.
|
|
|
Chavda, SJ;
Pocock, R;
Cheesman, S;
Lee, K-M;
Dowling, E;
Marks, DJB;
Kyriakou, C;
... Popat, R; + view all
(2020)
Association of hypertension and cardiac events in patients with multiple myeloma receiving carfilzomib: practical management recommendations.
British Journal of Haematology
10.1111/bjh.16889.
(In press).
|
|
|
Chen, LY;
Keddie, S;
Lunn, MP;
Bomsztyk, J;
Vitsaras, E;
Gupta, R;
D'Sa, S;
(2020)
IgM paraprotein-associated peripheral neuropathy: small CD20-positive B-cell clones may predict a monoclonal gammopathy of neurological significance and rituximab responsiveness.
British Journal of Haematology
, 188
(4)
pp. 511-515.
10.1111/bjh.16210.
|
|
Chicca, IJ;
Heaney, JLJ;
Iqbal, G;
Dunn, JA;
Bowcock, S;
Planche, T;
Pratt, G;
... Drayson, MT; + view all
(2020)
Stratifying risk of infection and response to therapy in patients with myeloma: a prognostic study.
Efficacy and Mechanism Evaluation
, 7
(10)
10.3310/eme07100.
|
|
|
Chicca, IJ;
Heaney, JLJ;
Iqbal, G;
Dunn, JA;
Bowcock, S;
Pratt, G;
Yong, KL;
... Drayson, MT; + view all
(2020)
Anti-bacterial antibodies in multiple myeloma patients at disease presentation, in response to therapy and in remission: implications for patient management.
Blood Cancer Journal
, 10
(11)
, Article 114. 10.1038/s41408-020-00370-7.
|
|
|
Chong, DLW;
Trinder, S;
Labelle, M;
Rodriguez-Justo, M;
Hughes, S;
Holmes, AM;
Scotton, CJ;
(2020)
Platelet-derived Transforming Growth Factor-β1 promotes keratinocyte proliferation in cutaneous wound healing.
Journal of Tissue Engineering and Regenerative Medicine
, 14
(4)
pp. 645-649.
10.1002/term.3022.
|
|
|
Chowdary, P;
Hamid, C;
Slatter, D;
Morris, R;
Foley, JH;
Gomez, K;
Brodkin, E;
... McVey, JH; + view all
(2020)
Impaired platelet-dependent thrombin generation associated with thrombocytopenia is improved by prothrombin complex concentrates in vitro.
Research and Practice in Thrombosis and Haemostasis
, 4
(2)
pp. 334-342.
10.1002/rth2.12310.
|
|
|
Chugh, R;
Ballman, KV;
Helman, LJ;
Patel, S;
Whelan, JS;
Widemann, B;
Lu, Y;
... Strauss, SJ; + view all
(2020)
SARC025 arms 1 and 2: A phase 1 study of the poly(ADP‐ribose) polymerase inhibitor niraparib with temozolomide or irinotecan in patients with advanced Ewing sarcoma.
Cancer
10.1002/cncr.33349.
|
|
|
Clarke, MA;
Fisher, J;
(2020)
Executable cancer models: successes and challenges.
Nature Reviews Cancer
, 20
pp. 343-354.
10.1038/s41568-020-0258-x.
|
|
Clarke, NW;
Ali, A;
Ingleby, FC;
Hoyle, A;
Amos, CL;
Attard, G;
Brawley, CD;
... STAMPEDE investigators; + view all
(2020)
Corrigendum to Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial: Ann Oncol 2019; 30: 1992-2003.
[Corrigendum].
Annals of Oncology
, 31
(3)
p. 442.
10.1016/j.annonc.2020.01.002.
|
|
|
Clesham, K;
Rao, V;
Bartram, J;
Ancliff, P;
Ghorashian, S;
O'Connor, D;
Pavasovic, V;
... Vora, A; + view all
(2020)
Blinatumomab for infant acute lymphoblastic leukemia.
Blood
, 135
(17)
pp. 1501-1504.
10.1182/blood.2019004008.
|
|
Cohen, H;
Cuadrado, MJ;
Erkan, D;
Duarte-Garcia, A;
Isenberg, DA;
Knight, JS;
Ortel, TL;
... Andrade, D; + view all
(2020)
16th International Congress on Antiphospholipid Antibodies Task Force Report on Antiphospholipid Syndrome Treatment Trends.
Lupus
, 29
(12)
pp. 1571-1593.
10.1177/0961203320950461.
|
|
Cohen, H;
Sayar, Z;
Efthymiou, M;
Gaspar, P;
Richards, T;
Isenberg, D;
(2020)
Management of anticoagulant-refractory thrombotic antiphospholipid syndrome.
The Lancet Haematology
, 7
(8)
e613-e623.
10.1016/S2352-3026(20)30116-2.
|
|
Cohen, OC;
Brodermann, MH;
Blakeney, IJ;
Mahmood, S;
Sachchithanantham, S;
Ravichandran, S;
Law, S;
... Wechalekar, AD; + view all
(2020)
Rapid response to single agent daratumumab is associated with improved progression-free survival in relapsed/refractory AL amyloidosis.
Amyloid
, 27
(3)
pp. 200-205.
10.1080/13506129.2020.1765768.
|
|
Cohen, OC;
Sharpley, F;
Gillmore, JD;
Lachmann, HJ;
Sachchithanantham, S;
Mahmood, S;
Fontana, M;
... Wechalekar, AD; + view all
(2020)
Use of ixazomib, lenalidomide and dexamethasone in patients with relapsed amyloid light‐chain amyloidosis.
British Journal of Haematology
, 189
(4)
pp. 643-649.
10.1111/bjh.16401.
|
|
Collier, T;
Smith, S;
Greenwood, M;
Ng, K;
(2020)
Living with Advanced Hormone-Sensitive Prostate Cancer and Treatment with Abiraterone and Androgen Deprivation Therapy: The Patient, Nursing and Physician Perspective.
Oncology and Therapy
10.1007/s40487-020-00132-2.
(In press).
|
|
|
Colomba, A;
Fitzek, M;
George, R;
Weitsman, G;
Roberts, S;
Zanetti-Domingues, L;
Hirsch, M;
... Parker, PJ; + view all
(2020)
A small molecule inhibitor of HER3: a proof-of-concept study.
Biochemical Journal
, 477
(17)
pp. 3329-3347.
10.1042/BCJ20200496.
|
|
|
Colombo, I;
Zaccarelli, E;
Del Grande, M;
Tomao, F;
Multinu, F;
Betella, I;
Ledermann, JA;
... Colombo, N; + view all
(2020)
ESMO management and treatment adapted recommendations in the COVID-19 era: gynaecological malignancies.
ESMO Open
, 5
, Article e000827. 10.1136/esmoopen-2020-000827.
|
|
|
Colombo, N;
Oza, AM;
Lorusso, D;
Aghajanian, C;
Oaknin, A;
Dean, A;
Weberpals, JI;
... Coleman, RL; + view all
(2020)
The effect of age on efficacy, safety and patient-centered outcomes with rucaparib: A post hoc exploratory analysis of ARIEL3, a phase 3, randomized, maintenance study in patients with recurrent ovarian carcinoma.
Gynecologic Oncology
10.1016/j.ygyno.2020.05.045.
(In press).
|
|
Comerford, AG;
Lucas, JAM;
Turner, TR;
Marsh, SGE;
Mayor, NP;
(2020)
The novel HLA-C*03:04:01:47 allele sequence identified using Pacific biosciences SMRT sequencing.
HLA: Immune Response Genetics
, 96
(4)
pp. 525-526.
10.1111/tan.14006.
|
|
|
Conduit, SE;
Davies, EM;
Ooms, LM;
Gurung, R;
McGrath, MJ;
Hakim, S;
Cottle, DL;
... Mitchell, CA; + view all
(2020)
AKT signaling promotes DNA damage accumulation and proliferation in polycystic kidney disease.
Human Molecular Genetics
, 29
(1)
pp. 31-48.
10.1093/hmg/ddz232.
|
|
Conduit, SE;
Vanhaesebroeck, B;
(2020)
Phosphoinositide lipids in primary cilia biology.
Biochemical Journal
, 477
(18)
pp. 3541-3565.
10.1042/BCJ20200277.
|
|
|
Corbett, S;
Huang, S;
Zammarchi, F;
Howard, PW;
van Berkel, PH;
Hartley, JA;
(2020)
The Role of Specific ATP-Binding Cassette Transporters in the Acquired Resistance to Pyrrolobenzodiazepine Dimer-Containing Antibody-Drug Conjugates.
Molecular Cancer Therapeutics
, 19
(9)
pp. 1856-1865.
10.1158/1535-7163.MCT-20-0222.
|
|
Correia Veloso Da Veiga, CI;
Chandy, E;
Jacob, J;
Yip, N;
Szmul, A;
Landau, D;
McClelland, J;
(2020)
Investigation of the evolution of radiation-induced lung damage using serial CT imaging and pulmonary function tests.
Radiotherapy and Oncology
, 148
pp. 89-96.
10.1016/j.radonc.2020.03.026.
|
|
|
Corrie, PG;
Qian, W;
Basu, B;
Valle, JW;
Falk, S;
Lwuji, C;
Wasan, H;
... Jodrell, DI; + view all
(2020)
Scheduling nab-paclitaxel combined with gemcitabine as first-line treatment for metastatic pancreatic adenocarcinoma.
British Journal of Cancer
10.1038/s41416-020-0846-2.
|
|
|
Cottone, L;
Cribbs, AP;
Khandelwal, G;
Wells, G;
Ligammari, L;
Philpott, M;
Tumber, A;
... Flanagan, AM; + view all
(2020)
Inhibition of Histone H3K27 Demethylases Inactivates Brachyury (TBXT) and Promotes Chordoma Cell Death.
Cancer Research
, 80
(20)
pp. 4540-4551.
10.1158/0008-5472.CAN-20-1387.
|
|
Cottone, L;
Eden, N;
Usher, I;
Lombard, P;
Ye, H;
Ligammari, L;
Lindsay, D;
... Flanagan, AM; + view all
(2020)
Frequent alterations in p16/CDKN2A identified by immunohistochemistry and FISH in chordoma.
Journal Of Pathology Clinical Research
, 6
(2)
pp. 113-123.
10.1002/cjp2.156.
|
|
|
Craig, Z;
Swain, J;
Batman, E;
Wadsley, J;
Reed, N;
Faluyi, O;
Cave, J;
... McNamara, MG; + view all
(2020)
NET-02 trial protocol: a multicentre, randomised, parallel group, open-label, phase II, single-stage selection trial of liposomal irinotecan (nal-IRI) and 5-fluorouracil (5-FU)/folinic acid or docetaxel as second-line therapy in patients with progressive poorly differentiated extrapulmonary neuroendocrine carcinoma (NEC).
BMJ Open
, 10
(2)
, Article e034527. 10.1136/bmjopen-2019-034527.
|
|
|
Crolley, VE;
Hanna, D;
Joharatnam-Hogan, N;
Chopra, N;
Bamac, E;
Desai, M;
Lam, YC;
... Khan, K; + view all
(2020)
COVID-19 in cancer patients on systemic anti-cancer therapies: outcomes from the CAPITOL (COVID-19 Cancer PatIenT Outcomes in North London) cohort study.
Therapeutic Advances in Medical Oncology
, 12
pp. 1-14.
10.1177/1758835920971147.
|
|
|
Crolley, VE;
Marashi, H;
Rawther, S;
Sirohi, B;
Parton, M;
Graham, J;
Vinayan, A;
... King, J; + view all
(2020)
The impact of Oncotype DX breast cancer assay results on clinical practice: a UK experience.
Breast Cancer Research and Treatment
, 180
pp. 809-817.
10.1007/s10549-020-05578-6.
|
|
|
Davidson, B;
Gurusamy, K;
Corrigan, N;
Croft, J;
Ruddock, S;
Pullan, A;
Brown, J;
... de Wilt, JH; + view all
(2020)
Liver resection surgery compared with thermal ablation in high surgical risk patients with colorectal liver metastases: the LAVA international RCT.
Health Technology Assessment
, 24
(21)
10.3310/hta24210.
|
|
|
Davis, LauraMay;
Smith, April-Louise;
Aldridge, Matthew D;
Foulkes, Jack;
Peet, Connie;
Wan, Simon;
Gains, Jennifer E;
... Gaze, Mark N; + view all
(2020)
Personalisation of Molecular Radiotherapy through Optimisation of Theragnostics.
Journal of Personalized Medicine
, 10
(4)
, Article 174. 10.3390/jpm10040174.
|
|
Dawes, JC;
Webster, P;
Iadarola, B;
Garcia-Diaz, C;
Dore, M;
Bolt, BJ;
Dewchand, H;
... Uren, AG; + view all
(2020)
LUMI-PCR: an Illumina platform ligation-mediated PCR protocol for integration site cloning, provides molecular quantitation of integration sites.
Mobile DNA
, 11
, Article 7. 10.1186/s13100-020-0201-4.
|
|
|
de Greef, PC;
Oakes, T;
Gerritsen, B;
Ismail, M;
Heather, JM;
Hermsen, R;
Chain, B;
(2020)
The naive T-cell receptor repertoire has an extremely broad distribution of clone sizes.
eLife
, 9
, Article e49900. 10.7554/eLife.49900.
|
|
|
De Noon, S;
Fleming, A;
Singh, M;
(2020)
Angiomatoid Fibrous Histiocytoma With ALK Expression in an Unusual Location and Age Group.
American Journal of Dermatopathology
, 42
(9)
pp. 689-693.
10.1097/DAD.0000000000001649.
|
|
DeGregori, James;
Pharoah, Paul;
Sasieni, Peter;
Swanton, Charles;
(2020)
Cancer Screening, Surrogates of Survival, and the Soma.
Cancer Cell
, 38
(4)
pp. 433-437.
10.1016/j.ccell.2020.09.003.
|
|
Dehbi, H-M;
Hackshaw, A;
(2020)
Sample size calculation in randomised phase II selection trials using a margin of practical equivalence.
Trials
, 21
, Article 301. 10.1186/s13063-020-04248-8.
|
|
|
Dertschnig, S;
Evans, P;
Santos e Sousa, P;
Manzo, T;
Ferrer, IR;
Stauss, HJ;
Bennett, CL;
(2020)
Graft-versus-host disease reduces lymph node display of tissue-restricted self-antigens and promotes autoimmunity.
The Journal of Clinical Investigation
10.1172/JCI133102.
(In press).
|
|
|
Desai, R;
East, DA;
Hardy, L;
Faccenda, D;
Rigon, M;
Crosby, J;
Alvarez, MS;
... Campanella, M; + view all
(2020)
Mitochondria form contact sites with the nucleus to couple prosurvival retrograde response.
Science Advances
, 6
(51)
, Article eabc9955. 10.1126/sciadv.abc9955.
|
|
|
Dieck, S;
Ibarra, M;
Moghul, I;
Yeung, MW;
Pantel, JT;
Thiele, S;
Pfau, M;
... Krawitz, PM; + view all
(2020)
Factors in color fundus photographs that can be used by humans to determine sex of individuals.
Translational Vision Science and Technology
, 9
(7)
, Article 8. 10.1167/tvst.9.7.8.
|
|
|
Dillon, R;
Hills, RK;
Freeman, SD;
Potter, N;
Jovanovic, J;
Ivey, A;
Kanda, AS;
... Grimwade, D; + view all
(2020)
Molecular MRD status and outcome after transplantation in NPM1 mutated AML: results from the UK NCRI AML17 study.
Blood
, 135
(9)
pp. 680-688.
10.1182/blood.2019002959.
|
|
Dimopoulos, MA;
Leleu, X;
Moreau, P;
Richardson, PG;
Liberati, AM;
Harrison, SJ;
Miles Prince, H;
... Yong, K; + view all
(2020)
Isatuximab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma patients with renal impairment: ICARIA-MM subgroup analysis.
Leukemia
10.1038/s41375-020-0868-z.
(In press).
|
|
Downes, Kate;
Borry, Pascal;
Ericson, Katrin;
Gomez, Keith;
Greinacher, Andreas;
Lambert, Michele;
Leinoe, Eva;
... Freson, Kathleen; + view all
(2020)
Clinical management, ethics and informed consent related to multi-gene panel-based high throughput sequencing testing for platelet disorders: Communication from the SSC of the ISTH.
Journal of Thrombosis and Haemostasis
, 18
(10)
pp. 2751-2758.
10.1111/jth.14993.
|
|
Drew, Y;
Kristeleit, RS;
Oaknin, A;
Ray-Coquard, I;
Haris, NM;
Swisher, EM;
(2020)
Real-World Delivery of Rucaparib to Patients with Ovarian Cancer: Recommendations Based on an Integrated Safety Analysis of ARIEL2 and Study 10.
The Oncologist
, 25
(1)
e109-e119.
10.1634/theoncologist.2019-0229.
|
|
|
Drilon, A;
Siena, S;
Dziadziuszko, R;
Barlesi, F;
Krebs, MG;
Shaw, AT;
de Braud, F;
... Doebele, RC; + view all
(2020)
Entrectinib in ROS1 fusion-positive non-small-cell lung cancer: integrated analysis of three phase 1-2 trials.
The Lancet Oncology
, 21
(2)
pp. 261-270.
10.1016/S1470-2045(19)30690-4.
|
|
Duggleby, Richard C;
Tsang, Hoi Pat;
Strange, Kathryn;
McWhinnie, Alasdair;
Lamikanra, Abigail A;
Roberts, David J;
Hernandez, Diana;
... Danby, Robert D; + view all
(2020)
Enumerating regulatory T cells in cryopreserved umbilical cord blood samples using FOXP3 methylation specific quantitative PCR.
PLoS ONE
, 15
(10)
, Article e0240190. 10.1371/journal.pone.0240190.
|
 |
|
Easom, NJW;
Marks, M;
Jobe, D;
Gillmore, R;
Meyer, T;
Maini, MK;
Njie, R;
(2020)
ULBP1 Is Elevated in Human Hepatocellular Carcinoma and Predicts Outcome.
Frontiers in Oncology
, 10
, Article 971. 10.3389/fonc.2020.00971.
|
|
|
Elyashiv, O;
Ledermann, J;
Parmar, G;
Farrelly, L;
Counsell, N;
Feeney, A;
El-Khouly, F;
... Nicum, S; + view all
(2020)
ICON 9-an international phase III randomized study to evaluate the efficacy of maintenance therapy with olaparib and cediranib or olaparib alone in patients with relapsed platinum-sensitive ovarian cancer following a response to platinum-based chemotherapy.
International Journal of Gynecologic Cancer
10.1136/ijgc-2020-002073.
(In press).
|
|
|
Enshaei, A;
O'Connor, D;
Bartram, J;
Hancock, J;
Harrison, CJ;
Hough, R;
Samarasinghe, S;
... Moorman, AV; + view all
(2020)
A validated novel continuous prognostic index to deliver stratified medicine in pediatric acute lymphoblastic leukemia.
Blood
, 135
(17)
pp. 1438-1446.
10.1182/blood.2019003191.
|
|
Eyre, TA;
Djebbari, F;
Kirkwood, AA;
Collins, GP;
(2020)
Efficacy of central nervous system prophylaxis with stand-alone intrathecal chemotherapy in diffuse large B-cell lymphoma patients treated with anthracycline-based chemotherapy in the rituximab era: a systematic review.
Haematologica
, 105
(7)
pp. 1914-1924.
10.3324/haematol.2019.229948.
|
|
|
Faivre-Finn, C;
Fenwick, JD;
Franks, KN;
Harrow, S;
Hatton, MQF;
Hiley, C;
McAleese, JJ;
... Toy, E; + view all
(2020)
Reduced Fractionation in Lung Cancer Patients Treated with Curative-intent Radiotherapy during the COVID-19 Pandemic.
Clinical Oncology
, 32
(8)
pp. 481-489.
10.1016/j.clon.2020.05.001.
|
|
Farah, N;
Burt, R;
Ibrahim, AR;
Baker, R;
Kottaridis, PD;
(2020)
Concerns about how to use established minimal residual disease monitoring in the treatment of NPM1-mutant acute myeloid leukaemia (AML) following reduced intensity chemotherapy protocols for AML given as a result of the COVID-19 pandemic.
British Journal of Haematology
, 190
(4)
E208-E210.
10.1111/bjh.16985.
|
|
Feldt-Rasmussen, U;
Hughes, D;
Sunder-Plassmann, G;
Shankar, S;
Nedd, K;
Olivotto, I;
Ortiz, D;
... Nicholls, K; + view all
(2020)
Long-term efficacy and safety of migalastat treatment in Fabry disease: 30-month results from the open-label extension of the randomized, phase 3 ATTRACT study.
Molecular Genetics and Metabolism
, 131
(1-2)
pp. 219-228.
10.1016/j.ymgme.2020.07.007.
|
|
|
Fennell, D;
Danson, S;
Woll, P;
Forster, M;
Talbot, D;
Child, J;
Farrelly, L;
... Wheeler, G; + view all
(2020)
Ganetespib in combination with pemetrexed-platinum chemotherapy in patients with pleural Mesothelioma (MESO-02): A phase Ib trial.
Clinical Cancer Research
, 26
(18)
pp. 4748-4755.
10.1158/1078-0432.CCR-20-1306.
|
|
Fenwick, JD;
Landau, DB;
Baker, AT;
Bates, AT;
Eswar, C;
Garcia-Alonso, A;
Harden, SV;
... Counsell, N; + view all
(2020)
Long-Term Results from the IDEAL-CRT Phase 1/2 Trial of Isotoxically Dose-Escalated Radiation Therapy and Concurrent Chemotherapy for Stage II/III Non-small Cell Lung Cancer.
International Journal of Radiation Oncology*Biology*Physics
, 106
(4)
pp. 733-742.
10.1016/j.ijrobp.2019.11.397.
|
|
|
Ferguson, MS;
Chard Dunmall, LS;
Gangeswaran, R;
Marelli, G;
Tysome, JR;
Burns, E;
Whitehead, MA;
... Wang, Y; + view all
(2020)
Transient Inhibition of PI3Kδ Enhances the Therapeutic Effect of Intravenous Delivery of Oncolytic Vaccinia Virus.
Molecular Therapy
10.1016/j.ymthe.2020.02.017.
(In press).
|
|
|
Feriozzi, S;
Linhart, A;
Ramaswami, U;
Kalampoki, V;
Gurevich, A;
Hughes, D;
Fabry Outcome Survey Study Group;
(2020)
Effects of Baseline Left Ventricular Hypertrophy and Decreased Renal Function on Cardiovascular and Renal Outcomes in Patients with Fabry Disease Treated with Agalsidase Alfa: A Fabry Outcome Survey Study.
Clinical Therapeutics
10.1016/j.clinthera.2020.10.007.
(In press).
|
|
|
Ferreira, R;
Napoli, J;
Enver, T;
Bernardino, L;
Ferreira, L;
(2020)
Advances and challenges in retinoid delivery systems in regenerative and therapeutic medicine.
Nature Communications
, 11
, Article 4265. 10.1038/s41467-020-18042-2.
|
|
|
Fielding, AK;
Goldstone, AH;
(2020)
Acute lymphoblastic leukaemia (ALL) things come to those who wait: 60 years of progress in the treatment of adult ALL.
British Journal of Haematology
, 191
(4)
pp. 558-561.
10.1111/bjh.17166.
|
|
|
Finn, RS;
Ikeda, M;
Zhu, AX;
Sung, MW;
Baron, AD;
Kudo, M;
Okusaka, T;
... Llovet, JM; + view all
(2020)
Phase Ib Study of Lenvatinib Plus Pembrolizumab in Patients With Unresectable Hepatocellular Carcinoma.
Journal of Clinical Oncology
10.1200/JCO.20.00808.
(In press).
|
|
|
Fittall, MW;
Lyskjær, I;
Ellery, P;
Lombard, P;
Ijaz, J;
Strobl, A-C;
Oukrif, D;
... Flanagan, AM; + view all
(2020)
Drivers underpinning the malignant transformation of giant cell tumour of bone.
The Journal of Pathology
10.1002/path.5537.
(In press).
|
|
|
Fontana, E;
Arkenau, H-T;
(2020)
Oncology clinical trials during the COVID-19 outbreak: Lessons learnt during the crisis and future opportunities.
Cancer Treatment Reviews
, 88
, Article 102047. 10.1016/j.ctrv.2020.102047.
|
|
|
Fostea, RM;
Fontana, E;
Torga, G;
Arkenau, HT;
(2020)
Recent Progress in the Systemic Treatment of Advanced/Metastatic Cholangiocarcinoma.
Cancers
, 12
(9)
, Article 2599. 10.3390/cancers12092599.
|
|
|
Fox, TA;
Troy-Barnes, E;
Kirkwood, AA;
Chan, WY;
Day, JW;
Chavda, SJ;
Kumar, EA;
... Ardeshna, KM; + view all
(2020)
Response to 'Impact of immunosuppression on mortality in critically ill COVID-19 patients'.
British Journal of Haematology
, 191
(3)
pp. 505-506.
10.1111/bjh.17110.
|
|
Fox, TA;
Halsey, R;
Pomplun, S;
Gant, V;
Grandage, V;
Mansour, MR;
Hough, R;
(2020)
Rapid clinical response to adjuvant corticosteroids in chronic disseminated candidiasis complicated by granulomas and persistent fever in acute leukemia patients.
Leukemia & Lymphoma
, 61
(4)
pp. 944-949.
10.1080/10428194.2019.1691198.
|
|
Fox, TA;
Troy-Barnes, E;
Kirkwood, AA;
Chan, WY;
Day, J;
Chavda, SJ;
Kumar, EA;
... Ardeshna, KM; + view all
(2020)
Clinical outcomes and risk factors for severe COVID‐19 infection in patients with haematological disorders receiving chemo‐ or immunotherapy.
British Journal of Haematology
, 191
(2)
pp. 194-206.
10.1111/bjh.17027.
|
|
Gadaleta, E;
Fourgoux, P;
Pirró, S;
Thorn, GJ;
Nelan, R;
Ironside, A;
Rajeeve, V;
... Chelala, C; + view all
(2020)
Characterization of four subtypes in morphologically normal tissue excised proximal and distal to breast cancer.
npj Breast Cancer
, 6
, Article 38. 10.1038/s41523-020-00182-9.
|
|
|
Gao, D;
Barber, PR;
Chacko, JV;
Kader Sagar, MA;
Rueden, CT;
Grislis, AR;
Hiner, MC;
(2020)
FLIMJ: An open-source ImageJ toolkit for fluorescence lifetime image data analysis.
PLoS One
, 15
(12)
, Article e0238327. 10.1371/journal.pone.0238327.
|
|
|
Garbowski, MW;
Bansal, S;
Porter, JB;
Mori, C;
Burckhardt, S;
Hider, RC;
(2020)
Intravenous iron preparations transiently generate non-transferrin-bound iron from two proposed pathways.
Haematologica
10.3324/haematol.2020.250803.
(In press).
|
|
Gaspar, P;
Cohen, H;
Isenberg, DA;
(2020)
The assessment of patients with the antiphospholipid antibody syndrome: where are we now?
Rheumatology
, 59
(7)
pp. 1489-1494.
10.1093/rheumatology/keaa172.
|
|
Gerrand, C;
Bate, J;
Seddon, B;
Dirksen, U;
Randall, RL;
van de Sande, M;
O'Donnell, P;
... Whelan, J; + view all
(2020)
Seeking international consensus on approaches to primary tumour treatment in Ewing sarcoma.
Clinical Sarcoma Research
, 10
, Article 21. 10.1186/s13569-020-00144-6.
|
|
|
Gerstung, M;
Jolly, C;
Leshchiner, I;
Dentro, SC;
Gonzalez, S;
Rosebrock, D;
Mitchell, TJ;
... PCAWG Consortium, .; + view all
(2020)
The evolutionary history of 2,658 cancers.
Nature
, 578
(7793)
pp. 122-128.
10.1038/s41586-019-1907-7.
|
|
|
Gewandter, JS;
Dworkin, RH;
Turk, DC;
Devine, EG;
Hewitt, D;
Jensen, MP;
Katz, NP;
... Witter, J; + view all
(2020)
Improving Study Conduct and Data Quality in Clinical Trials of Chronic Pain Treatments: IMMPACT Recommendations.
The Journal of Pain
, 21
(9-10)
pp. 931-942.
10.1016/j.jpain.2019.12.003.
|
|
Ghorani, E;
Reading, JL;
Henry, JY;
Massy, MRD;
Rosenthal, R;
Turati, V;
Joshi, K;
... Quezada, SA; + view all
(2020)
The T cell differentiation landscape is shaped by tumour mutations in lung cancer.
Nature Cancer
, 1
(5)
pp. 546-561.
10.1038/s43018-020-0066-y.
|
|
Giansily‐Blaizot, M;
Rallapalli, PM;
Perkins, SJ;
Kemball‐Cook, G;
Hampshire, DJ;
Gomez, K;
Ludlam, CA;
(2020)
The EAHAD blood coagulation factor VII variant database.
Human Mutation
10.1002/humu.24025.
(In press).
|
|
|
Gillessen, S;
Attard, G;
Beer, TM;
Beltran, H;
Bjartell, A;
Bossi, A;
Briganti, A;
... Omlin, A; + view all
(2020)
Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019.
European Urology
10.1016/j.eururo.2020.01.012.
(In press).
|
|
|
Gilson, C;
Ingleby, F;
Gilbert, DC;
Parry, MA;
Atako, NB;
Ali, A;
Hoyle, A;
... Chowdhury, S; + view all
(2020)
Genomic Profiles of De Novo High- and Low-Volume Metastatic Prostate Cancer: Results From a 2-Stage Feasibility and Prevalence Study in the STAMPEDE Trial.
JCO Precision Oncology
, 4
pp. 882-897.
10.1200/po.19.00388.
|
|
Glynne-Jones, R;
Meadows, HM;
Lopes, A;
Muirhead, R;
Sebag-Montefiore, D;
Adams, R;
ACTII study group;
(2020)
Impact of compliance to chemoradiation on long-term outcomes in squamous cell carcinoma of the anus. Results of a post-hoc analysis from the randomized phase III ACT II trial.
Annals of Oncology
, 31
(10)
pp. 1376-1385.
10.1016/j.annonc.2020.06.012.
|
|
Glynne-Jones, R;
Meadows, HM;
Lopes, A;
Riddle, P;
Duggan, M;
Sebag-Montefiore, D;
McDonald, A;
... Adams, R; + view all
(2020)
A Phase I/II Feasibility Study of Intravenous Cetuximab in Combination with 5 days Weekly Oral Capecitabine and Preoperative Radiotherapy in Rectal Cancer (XERXES).
Archives of Clinical and Biomedical Research
, 4
(4)
pp. 394-412.
10.26502/acbr.50170112.
|
|
|
Gomez, V;
(2020)
Breast cancer-associated macrophages promote tumorigenesis by suppressing succinate dehydrogenase in tumor cells.
Science Signaling
, 13
(652)
, Article eaax4585. 10.1126/scisignal.aax4585.
|
|
Gomez, V;
Mustapha, R;
Ng, K;
Ng, T;
(2020)
Radiation therapy and the innate immune response: clinical implications for immunotherapy approaches.
British Journal of Clinical Pharmacology
, 86
(9)
pp. 1726-1735.
10.1111/bcp.14351.
|
|
|
Goncalves, T;
Zoumpoulidou, G;
Alvarez-Mendoza, C;
Mancusi, C;
Collopy, LC;
Strauss, SJ;
Mittnacht, S;
(2020)
Selective Elimination of Osteosarcoma Cell Lines with Short Telomeres by Ataxia Telangiectasia and Rad3-Related Inhibitors.
ACS Pharmacology & Translational Science
, 3
(6)
pp. 1253-1264.
10.1021/acsptsci.0c00125.
|
|
Gonzalez-Ericsson, P;
Stovgaard, ES;
Sua, LF;
Reisenbichler, E;
Kos, Z;
Carter, JM;
Michiels, S;
... Sanders, M; + view all
(2020)
The path to a better biomarker: application of a risk management framework for the implementation of PD-L1 and TILs as immuno-oncology biomarkers in breast cancer clinical trials and daily practice.
The Journal of Pathology
, 250
(5)
pp. 667-684.
10.1002/path.5406.
|
|
Goswami, P;
Oliva, EN;
Ionova, T;
Else, R;
Kell, J;
Fielding, AK;
Jennings, DM;
... Salek, S; + view all
(2020)
Hematological Malignancy Specific Patient-Reported Outcome Measure (HM-PRO): Construct Validity Study.
Frontiers in Pharmacology
, 11
, Article 1308. 10.3389/fphar.2020.01308.
|
|
|
Goswami, P;
Oliva, EN;
Ionova, T;
Else, R;
Kell, J;
Fielding, AK;
Jennings, DM;
... Salek, S; + view all
(2020)
Reliability of a Novel Hematological Malignancy Specific Patient-Reported Outcome Measure: HM-PRO.
Frontiers in Pharmacology
, 11
, Article 571066. 10.3389/fphar.2020.571066.
|
|
|
Goswami, P;
Oliva, EN;
Ionova, T;
Else, R;
Kell, J;
Fielding, AK;
Jennings, DM;
... Salek, S; + view all
(2020)
Development of a Novel Hematological Malignancy Specific Patient-Reported Outcome Measure (HM-PRO): Content Validity.
Frontiers in Pharmacology
, 11
, Article 209. 10.3389/fphar.2020.00209.
|
|
|
Goswami, P;
Oliva, EN;
Ionova, T;
Else, R;
Kell, J;
Fielding, AK;
Jennings, DM;
... Salek, S; + view all
(2020)
Quality-of-life issues and symptoms reported by patients living with haematological malignancy: a qualitative study.
Therapeutic Advances in Hematology
, 11
pp. 1-14.
10.1177/2040620720955002.
|
|
|
Gourley, C;
Miller, RE;
Hollis, RL;
Ledermann, JA;
(2020)
Role of Poly (ADP-Ribose) Polymerase inhibitors beyond BReast CAncer Gene-mutated ovarian tumours: definition of homologous recombination deficiency?
Current Opinion in Oncology
, 32
(5)
pp. 442-450.
10.1097/CCO.0000000000000660.
|
|
Granai, M;
Mundo, L;
Akarca, AU;
Siciliano, MC;
Rizvi, H;
Mancini, V;
Onyango, N;
... Marafioti, T; + view all
(2020)
Immune landscape in Burkitt lymphoma reveals M2-macrophage polarization and correlation between PD-L1 expression and non-canonical EBV latency program.
Infectious Agents and Cancer
, 15
, Article 28. 10.1186/s13027-020-00292-w.
|
|
|
Grayling, MJ;
Wheeler, GM;
(2020)
A review of available software for adaptive clinical trial design.
Clinical Trials
10.1177/1740774520906398.
(In press).
|
|
|
Grieco, G;
Wang, T;
Delcorte, O;
Spourquet, C;
Janssens, V;
Strickaert, A;
Gaide Chevronnay, H;
... Pierreux, CE; + view all
(2020)
Vps34 PI 3-kinase controls thyroid hormone production by regulating thyroglobulin iodination, lysosomal proteolysis and tissue homeostasis.
Thyroid
, 30
(1)
pp. 133-146.
10.1089/thy.2019.0182.
|
|
Grimes, DR;
Jansen, M;
Macauley, RJ;
Scott, JG;
Basanta, D;
(2020)
Evidence for hypoxia increasing the tempo of evolution in glioblastoma.
British Journal of Cancer
10.1038/s41416-020-1021-5.
(In press).
|
|
|
Gripp, KW;
Schill, L;
Schoyer, L;
Stronach, B;
Bennett, AM;
Blaser, S;
Brown, A;
... Ratner, N; + view all
(2020)
The sixth international RASopathies symposium: Precision medicine—From promise to practice.
American Journal of Medical Genetics Part A
, 182
(3)
pp. 597-606.
10.1002/ajmg.a.61434.
|
|
Guerra-Assunção, JA;
Conde, L;
Moghul, I;
Webster, AP;
Ecker, S;
Chervova, O;
Chatzipantsiou, C;
... Herrero, J; + view all
(2020)
GenomeChronicler: The Personal Genome Project UK Genomic Report Generator Pipeline.
Frontiers in Genetics
, 11
, Article 518644. 10.3389/fgene.2020.518644.
|
|
|
Guillotin, D;
Taylor, AR;
Platé, M;
Mercer, PF;
Edwards, LM;
Haggart, R;
Miele, G;
... Chambers, RC; + view all
(2020)
Transcriptome analysis of IPF fibroblastic foci identifies key pathways involved in fibrogenesis.
Thorax
, 76
(1)
pp. 73-82.
10.1136/thoraxjnl-2020-214902.
|
 |
|
Gupta, R;
Gant, VA;
Williams, B;
Enver, T;
(2020)
Increased Complement Receptor-3 levels in monocytes and granulocytes distinguish COVID-19 patients with pneumonia from those with mild symptoms.
International Journal of Infectious Diseases
10.1016/j.ijid.2020.08.004.
(In press).
|
|
|
Gupta, R;
Turati, V;
Brian, D;
Thrussel, C;
Wilbourn, B;
May, G;
Enver, T;
(2020)
Nov/CCN3 Enhances Cord Blood Engraftment by Rapidly Recruiting Latent Human Stem Cell Activity.
Cell Stem Cell
10.1016/j.stem.2020.02.012.
(In press).
|
|
Hainsworth, EG;
Shahmanesh, M;
Stevenson, F;
(2020)
Insights into the social context of living with a dual diagnosis of HIV and cancer: a qualitative, thematic analysis of popular discourse in London newspapers.
AIDS Care
, 32
(6)
pp. 793-799.
10.1080/09540121.2019.1653444.
|
|
Hall, MR;
Dehbi, H-M;
Banerjee, S;
Lord, R;
Clamp, A;
Ledermann, JA;
Nicum, S;
... Rustin, G; + view all
(2020)
A phase II randomised, placebo-controlled trial of low dose (metronomic) cyclophosphamide and nintedanib (BIBF1120) in advanced ovarian, fallopian tube or primary peritoneal cancer.
Gynecologic Oncology
, 159
(3)
pp. 692-698.
10.1016/j.ygyno.2020.09.048.
|
|
Hall, BA;
Fisher, J;
(2020)
Constructing and Analyzing Computational Models of Cell Signaling with BioModelAnalyzer.
Current Protocols in Bioinformatics
, 69
(1)
, Article e95. 10.1002/cpbi.95.
|
|
Hamilton, NJI;
Lee, DDH;
Gowers, KHC;
Butler, CR;
Maughan, EF;
Jevans, B;
Orr, JC;
... Janes, SM; + view all
(2020)
Bioengineered airway epithelial grafts with mucociliary function based on collagen IV- and laminin-containing extracellular matrix scaffolds.
European Respiratory Journal
, 55
, Article 1901200. 10.1183/13993003.01200-2019.
|
|
|
Harrington, KJ;
Bhide, SA;
Forster, MD;
Good, JS;
Gunn, L;
Kong, A;
Melcher, AA;
... Wong, KH; + view all
(2020)
Looking a Gift Horse in the Mouth: Observations on NHS England's Interim Guidance on Pembrolizumab in Head and Neck Squamous Cell Cancer.
Clinical Oncology
, 32
(8)
pp. 490-492.
10.1016/j.clon.2020.05.016.
|
|
|
Harter, P;
Pautier, P;
Van Nieuwenhuysen, E;
Reuss, A;
Redondo, A;
Lindemann, K;
Kurzeder, C;
... Marme, F; + view all
(2020)
Atezolizumab in combination with bevacizumab and chemotherapy versus bevacizumab and chemotherapy in recurrent ovarian cancer - a randomized phase III trial (AGO-OVAR 2.29/ENGOT-ov34).
International Journal of Gynecologic Cancer
10.1136/ijgc-2020-001572.
(In press).
|
|
|
Herbst, RS;
Arkenau, HT;
Bendell, J;
Arrowsmith, E;
Wermke, M;
Soriano, A;
Penel, N;
... Paz-Ares, L; + view all
(2020)
Phase 1 Expansion Cohort of Ramucirumab Plus Pembrolizumab in Advanced Treatment-Naive NSCLC.
Journal of Thoracic Oncology
, 16
(2)
pp. 289-298.
10.1016/j.jtho.2020.10.004.
|
|
|
Herbst, RS;
Garon, EB;
Kim, D-W;
Cho, BC;
Perez-Gracia, JL;
Han, J-Y;
Arvis, CD;
... Baas, P; + view all
(2020)
Long-Term Outcomes and Retreatment Among Patients With Previously Treated, Programmed Death-Ligand 1Positive, Advanced NonSmall-Cell Lung Cancer in the KEYNOTE-010 Study.
Journal of Clinical Oncology
, 38
(14)
pp. 1580-1590.
10.1200/JCO.19.02446.
|
|
Hiley, C;
Salem, A;
Batchelor, T;
McDonald, F;
Evison, M;
(2020)
Great debate: surgery versus stereotactic radiotherapy for early-stage non-small cell lung cancer.
Thorax
, 75
(3)
pp. 198-199.
10.1136/thoraxjnl-2019-214014.
|
|
|
Hockings, C;
Gohil, S;
Dowse, R;
Hoade, Y;
Mansour, MR;
Gale, RE;
Linch, DC;
... Payne, EM; + view all
(2020)
In trans early mosaic mutational escape and novel phenotypic features of germline SAMD9 mutation.
British Journal of Haematology
, 188
(4)
e53-e57.
10.1111/bjh.16322.
|
|
Hoffman, HI;
Guo, JA;
Hawkins, MA;
Bridgewater, JA;
Wo, JY;
Hong, TS;
Hwang, WL;
(2020)
Silver Linings: An Opportunity to Improve Clinical Paradigms After the COVID-19 Pandemic.
JCO Oncology Practice
10.1200/OP.20.00335.
(In press).
|
|
Hong, DS;
Concin, N;
Vergote, I;
de Bono, JS;
Slomovitz, BM;
Drew, Y;
Arkenau, H-T;
... Coleman, RL; + view all
(2020)
Tisotumab Vedotin in Previously Treated Recurrent or Metastatic Cervical Cancer.
Clinical Cancer Research
, 26
(6)
pp. 1220-1228.
10.1158/1078-0432.CCR-19-2962.
|
|
Hostettler, IC;
Morton, MJ;
Ambler, G;
Kazmi, N;
Gaunt, T;
Wilson, D;
Shakeshaft, C;
... CROMIS-2 collaborators; + view all
(2020)
Haptoglobin genotype and outcome after spontaneous intracerebral haemorrhage.
Journal of Neurology, Neurosurgery and Psychiatry
, 91
(3)
pp. 298-304.
10.1136/jnnp-2019-321774.
|
|
|
Houlihan, CF;
Vora, N;
Byrne, T;
Lewer, D;
Kelly, G;
Heaney, J;
Gandhi, S;
... SAFER Investigators; + view all
(2020)
Pandemic peak SARS-CoV-2 infection and seroconversion rates in London frontline health-care workers.
The Lancet
, 396
(10246)
e6-e7.
10.1016/S0140-6736(20)31484-7.
|
|
|
Howard, Emma L;
Gregory, Jonathan;
Tsoi, Kim;
Evans, Scott;
Flanagan, Adrienne;
Cool, Paul;
(2020)
Comorbidities and Pregnancy Do Not Affect Local Recurrence in Patients With Giant Cell Tumour of Bone.
Cureus: Journal of Medical Science
, 12
(7)
, Article e9164. 10.7759/cureus.9164.
|
|
|
Howie, Alexander J;
Owen-Casey, Mared P;
(2020)
"Green/apple-green birefringence": unfit for purpose?
Kidney International
, 98
(5)
p. 1350.
10.1016/j.kint.2020.07.029.
|
|
Hudeček, J;
Voorwerk, L;
van Seijen, M;
Nederlof, I;
de Maaker, M;
van den Berg, J;
van de Vijver, KK;
... Peale, F; + view all
(2020)
Application of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trials.
npj Breast Cancer
, 6
, Article 15. 10.1038/s41523-020-0155-1.
|
|
|
Hughes, DA;
Aguiar, P;
Deegan, PB;
Ezgu, F;
Frustaci, A;
Lidove, O;
Linhart, A;
... Feriozzi, S; + view all
(2020)
Early indicators of disease progression in Fabry disease that may indicate the need for disease-specific treatment initiation: findings from the opinion-based PREDICT-FD modified Delphi consensus initiative.
BMJ Open
, 10
(10)
, Article e035182. 10.1136/bmjopen-2019-035182.
|
|
|
Hutachok, N;
Angkasith, P;
Chumpun, C;
Fucharoen, S;
Mackie, IJ;
Porter, JB;
Srichairatanakool, S;
(2020)
Anti-Platelet Aggregation and Anti-Cyclooxygenase Activities for a Range of Coffee Extracts (Coffea arabica).
Molecules
, 26
, Article 10. 10.3390/molecules26010010.
|
|
|
Hutchison, I;
Hackshaw, A;
(2020)
Reply to Comment(s) on "Nationwide randomised trial evaluating elective neck dissection for early stage oral cancer (SEND study) with meta-analysis and concurrent real-world cohort".
British Journal of Cancer
, 123
pp. 1200-1201.
10.1038/s41416-020-0983-7.
|
|
Illidge, TM;
Phillips, EH;
Counsell, N;
Pettengell, R;
Johnson, PWM;
Culligan, DJ;
Popova, B;
... Radford, J; + view all
(2020)
Maximum tumor diameter is associated with event-free survival in PET-negative patients with stage I/IIA Hodgkin lymphoma.
Blood Advances
, 4
(1)
pp. 203-206.
10.1182/bloodadvances.2019001023.
|
|
|
Israelsen, M;
Guerrero Misas, M;
Koutsoumourakis, A;
Huang, Y;
Thiele, M;
Hall, A;
Rasmussen, D;
... Tsochatzis, EA; + view all
(2020)
Collagen proportionate area predicts clinical outcomes in
patients with alcohol-related liver disease.
Alimentary Pharmacology and Therapeutics
10.1111/apt.16111.
(In press).
|
|
|
Iyer, RV;
Acquisto, SG;
Bridgewater, JA;
Choti, MA;
Hong, TS;
Kis, B;
Mead, PA;
... Valle, JW; + view all
(2020)
Guidelines for Management of Urgent Symptoms in Patients with Cholangiocarcinoma and Biliary Stents or Catheters Using the Modified RAND/UCLA Delphi Process.
Cancers
, 12
(9)
, Article 2375. 10.3390/cancers12092375.
|
|
|
Jamieson, L;
Forster, MD;
Zaki, K;
Mitra, S;
Alli, H;
O’Connor, A;
Patel, A;
... Chambers, PC; + view all
(2020)
Immunotherapy and associated immune-related adverse events at a large UK centre: a mixed methods study.
BMC Cancer
, 20
, Article 743. 10.1186/s12885-020-07215-3.
|
|
|
Joharatnam-Hogan, N;
Hochhauser, D;
Shiu, K-K;
Rush, H;
Crolley, V;
Wilson, W;
Sharma, A;
... Khan, K; + view all
(2020)
Outcomes of the 2019 novel coronavirus in patients with or without a history of cancer: a multi-centre North London experience.
Therapeutic Advances in Medical Oncology
pp. 1-9.
10.1177/1758835920956803.
|
|
Joharatnam-Hogan, N;
Shiu, KK;
Khan, K;
(2020)
Challenges in the treatment of gastric cancer in the older patient.
Cancer Treatment Reviews
, 85
, Article 101980. 10.1016/j.ctrv.2020.101980.
|
|
|
Joharatnam-Hogan, N;
Wilson, W;
Shiu, KK;
Fusai, GK;
Davidson, B;
Hochhauser, D;
Bridgewater, J;
(2020)
Multimodal Treatment in Metastatic Colorectal Cancer (mCRC) Improves Outcomes—The University College London Hospital (UCLH) Experience.
Cancers
, 12
(12)
, Article 3545. 10.3390/cancers12123545.
|
|
|
Jones, CM;
Radhakrishna, G;
Aitken, K;
Bridgewater, J;
Corrie, P;
Eatock, M;
Goody, R;
... Mukherjee, S; + view all
(2020)
Considerations for the treatment of pancreatic cancer during the COVID-19 pandemic: the UK consensus position.
British Journal of Cancer
, 123
pp. 709-713.
10.1038/s41416-020-0980-x.
|
|
Jones, M;
Beuron, F;
Borg, A;
Nans, A;
Earl, CP;
Briggs, DC;
Snijders, AP;
... McDonald, NQ; + view all
(2020)
Cryo-EM structures of the XPF-ERCC1 endonuclease reveal how DNA-junction engagement disrupts an auto-inhibited conformation.
Nature Communications
, 11
(1)
, Article 1120. 10.1038/s41467-020-14856-2.
|
|
|
Jones, S;
King, PJ;
Antonescu, CN;
Sugiyama, MG;
Bhamra, A;
Surinova, S;
Angelopoulos, N;
... Hochhauser, D; + view all
(2020)
Targeting of EGFR by a combination of antibodies mediates unconventional EGFR trafficking and degradation.
Scientific Reports
, 10
, Article 663. 10.1038/s41598-019-57153-9.
|
|
|
Kalam, S;
Beale, R;
Hughes, D;
Kulasekararaj, A;
Srirangalingam, U;
(2020)
Coombs-positive Paroxysmal Nocturnal Haemoglobinuria.
Oxford Medical Case Reports
(3)
, Article omz125. 10.1093/omcr/omz125.
|
|
|
Kantaris, X;
Shevlin, M;
Porter, J;
Myers, L;
(2020)
Development of the Thalassaemia Adult Life Index (ThALI).
Health and Quality of Life Outcomes
, 18
, Article 180. 10.1186/s12955-020-01437-6.
|
|
|
Karda, R;
Rahim, AA;
Wong, AMS;
Suff, N;
Diaz, JA;
Perocheau, DP;
Tijani, M;
... Waddington, SN; + view all
(2020)
Generation of light-producing somatic-transgenic mice using adeno-associated virus vectors.
Scientific Reports
, 10
(1)
, Article 2121. 10.1038/s41598-020-59075-3.
|
|
|
Keddie, S;
Foldes, D;
Caimari, F;
Baldeweg, SE;
Bomsztyk, J;
Ziff, OJ;
Fehmi, J;
... Lunn, MP; + view all
(2020)
Clinical characteristics, risk factors, and outcomes of POEMS syndrome: A longitudinal cohort study.
Neurology
, 95
(3)
e268-e279.
10.1212/WNL.0000000000009940.
|
|
Keddie, S;
Nagendran, A;
Cox, T;
Bomsztyk, J;
Jaunmuktane, Z;
Brandner, S;
Manji, H;
... Lunn, MP; + view all
(2020)
Peripheral nerve neurolymphomatosis: clinical features, treatment and outcomes.
Muscle & Nerve
, 62
(5)
pp. 617-625.
10.1002/mus.27045.
|
|
Kelley, RK;
Bridgewater, J;
Gores, GJ;
Zhu, AX;
(2020)
Systemic therapies for intrahepatic cholangiocarcinoma.
Journal of Hepatology
, 72
(2)
pp. 353-363.
10.1016/j.jhep.2019.10.009.
|
|
Kelley, RK;
Meyer, T;
Rimassa, L;
Merle, P;
Park, J-W;
Yau, T;
Chan, SL;
... Abou-Alfa, GK; + view all
(2020)
Serum Alpha-fetoprotein Levels and Clinical Outcomes in the Phase III CELESTIAL Study of Cabozantinib versus Placebo in Patients with Advanced Hepatocellular Carcinoma.
Clinical Cancer Research
, 26
(18)
pp. 4795-4804.
10.1158/1078-0432.CCR-19-3884.
|
|
Kelley, RK;
Ryoo, B-Y;
Merle, P;
Park, J-W;
Bolondi, L;
Chan, SL;
Lim, HY;
... Abou-Alfa, GK; + view all
(2020)
Second-line cabozantinib after sorafenib treatment for advanced hepatocellular carcinoma: a subgroup analysis of the phase 3 CELESTIAL trial.
ESMO Open
, 5
(4)
, Article e000714. 10.1136/esmoopen-2020-000714.
|
|
|
Khalil, AME;
Memon, FA;
Tabish, TA;
Salmon, D;
Zhang, S;
Butler, D;
(2020)
Nanostructured porous graphene for efficient removal of emerging contaminants (pharmaceuticals) from water.
Chemical Engineering Journal
, 398
, Article 125440. 10.1016/j.cej.2020.125440.
|
|
Khawaja, AA;
Chong, DLW;
Sahota, J;
Mikolasch, TA;
Pericleous, C;
Ripoll, VM;
Booth, HL;
... Porter, JC; + view all
(2020)
Identification of a Novel HIF-1α-α_{M}β_{2} Integrin-NET Axis in Fibrotic Interstitial Lung Disease.
Frontiers in Immunology
, 11
, Article 2190. 10.3389/fimmu.2020.02190.
|
|
|
Kong, A;
Good, J;
Kirkham, A;
Savage, J;
Mant, R;
Llewellyn, L;
Parish, J;
... Mehanna, H; + view all
(2020)
Phase I trial of WEE1 inhibition with chemotherapy and radiotherapy as adjuvant treatment, and a window of opportunity trial with cisplatin in patients with head and neck cancer: the WISTERIA trial protocol.
BMJ Open
, 10
(3)
, Article e033009. 10.1136/bmjopen-2019-033009.
|
|
|
Koo, MM;
Lyratzopoulos, G;
Herbert, A;
Abel, GA;
Taylor, RM;
Barber, JA;
Gibson, F;
... Fern, LA; + view all
(2020)
Association of Self-reported Presenting Symptoms With Timeliness
of Help-Seeking Among Adolescents and Young Adults With Cancer
in the BRIGHTLIGHT Study.
JAMA Network Open
, 3
(9)
, Article e2015437. 10.1001/jamanetworkopen.2020.15437.
|
|
|
Kos, Z;
Roblin, E;
Kim, RS;
Michiels, S;
Gallas, BD;
Chen, W;
van de Vijver, KK;
... International Immuno-Oncology Biomarker Working Group; + view all
(2020)
Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer.
NPJ Breast Cancer
, 6
, Article 17. 10.1038/s41523-020-0156-0.
|
|
|
Koutoukidis, DA;
Land, J;
Hackshaw, A;
Heinrich, M;
McCourt, O;
Beeken, RJ;
Philpott, S;
... Yong, KL; + view all
(2020)
Fatigue, quality of life and physical fitness following an exercise intervention in multiple myeloma survivors (MASCOT): an exploratory randomised Phase 2 trial utilising a modified Zelen design.
British Journal of Cancer
10.1038/s41416-020-0866-y.
(In press).
|
|
|
Koutoukidis, DA;
Land, J;
Hackshaw, A;
Heinrich, M;
McCourt, O;
Beeken, RJ;
Philpott, S;
... Yong, KL; + view all
(2020)
Fatigue, quality of life and physical fitness following an exercise intervention in multiple myeloma survivors (MASCOT): an exploratory randomised Phase 2 trial utilising a modified Zelen design.
British Journal of Cancer
10.1038/s41416-020-0866-y.
(In press).
|
|
|
Kristeleit, R;
Evans, J;
Molife, LR;
Tunariu, N;
Shaw, H;
Slater, S;
Haris, NRM;
... Lopez, J; + view all
(2020)
Phase 1/2a trial of intravenous BAL101553, a novel controller of the spindle assembly checkpoint, in advanced solid tumours.
British Journal of Cancer
10.1038/s41416-020-1010-8.
(In press).
|
|
|
Kurzrock, R;
Bowles, DW;
Kang, H;
Meric-Bernstam, F;
Hainsworth, J;
Spigel, DR;
Bose, R;
... Swanton, C; + view all
(2020)
Targeted therapy for advanced salivary gland carcinoma based on molecular profiling: results from MyPathway, a phase IIa multiple basket study.
Annals of Oncology
, 31
(3)
pp. 412-421.
10.1016/j.annonc.2019.11.018.
|
|
|
Labeur, TA;
Berhane, S;
Edeline, J;
Blanc, J-F;
Bettinger, D;
Meyer, T;
Van Vugt, JLA;
... Johnson, PJ; + view all
(2020)
Improved survival prediction and comparison of prognostic models for patients with hepatocellular carcinoma treated with sorafenib.
Liver International
, 40
(1)
pp. 215-228.
10.1111/liv.14270.
|
|
|
Ladenstein, R;
Pötschger, U;
Valteau-couanet, D;
Luksch, R;
Castel, V;
Ash, S;
Laureys, G;
... Lode, HN; + view all
(2020)
Investigation of the Role of Dinutuximab Beta-Based Immunotherapy in the SIOPEN High-Risk Neuroblastoma 1 Trial (HR-NBL1).
Cancers
, 12
(2)
, Article 309. 10.3390/cancers12020309.
|
|
Lai, AG;
Pasea, L;
Banerjee, A;
Hall, G;
Denaxas, S;
Chang, WH;
Katsoulis, M;
... Hemingway, H; + view all
(2020)
Estimated impact of the COVID-19 pandemic on cancer services and excess 1-year mortality in people with cancer and multimorbidity: near real-time data on cancer care, cancer deaths and a population-based cohort study.
BMJ Open
, 10
(11)
, Article e043828. 10.1136/bmjopen-2020-043828.
|
|
|
Lakatos, E;
Williams, MJ;
Schenck, RO;
Cross, WCH;
Househam, J;
Zapata, L;
Werner, B;
... Graham, TA; + view all
(2020)
Evolutionary dynamics of neoantigens in growing tumors.
Nature Genetics
, 52
pp. 1057-1066.
10.1038/s41588-020-0687-1.
|
|
Lamarca, A;
Edeline, J;
McNamara, MG;
Hubner, RA;
Nagino, M;
Bridgewater, J;
Primrose, J;
(2020)
Current standards and future perspectives in adjuvant treatment for biliary tract cancers.
Cancer Treatment Reviews
, 84
, Article 101936. 10.1016/j.ctrv.2019.101936.
|
|
Land, J;
McCourt, O;
Heinrich, M;
Beeken, RJ;
Koutoukidis, DA;
Paton, B;
Yong, K;
... Fisher, A; + view all
(2020)
The adapted Zelen was a feasible design to trial exercise in myeloma survivors.
Journal of Clinical Epidemiology
, 125
pp. 76-83.
10.1016/j.jclinepi.2020.04.004.
|
|
|
Latifoltojar, A;
Duncan, MKJ;
Klusmann, M;
Sidhu, H;
Bainbridge, A;
Neriman, D;
Fraioli, F;
... Punwani, S; + view all
(2020)
Whole Body 3.0 T Magnetic Resonance Imaging in Lymphomas: Comparison of Different Sequence Combinations for Staging Hodgkin's and Diffuse Large B Cell Lymphomas.
Journal of Personalized Medicine
, 10
(4)
, Article 284. 10.3390/jpm10040284.
|
|
|
Lauder, SN;
Smart, K;
Kersemans, V;
Allen, D;
Scott, J;
Pires, A;
Milutinovic, S;
... Gallimore, A; + view all
(2020)
Enhanced antitumor immunity through sequential targeting of PI3Kδ and LAG3.
Journal for Immuno Therapy of Cancer
, 8
(2)
, Article e000693. 10.1136/jitc-2020-000693.
|
|
|
Lecat, CSY;
Besley, C;
Hough, RE;
Khwaja, A;
Furness, C;
Marks, DI;
Fielding, AK;
(2020)
Inotuzumab ozogamicin versus FLAG-Ida in the treatment of relapsed or refractory B-cell acute lymphoblastic leukemia – real-world resource use data.
Leukemia & Lymphoma
, 61
(2)
pp. 491-493.
10.1080/10428194.2019.1672057.
|
|
Lechner, M;
Counsell, N;
Liu, J;
Eynon-Lewis, N;
Paun, S;
Lund, VJ;
Jayaraj, S;
(2020)
Anosmia and hyposmia in health-care workers with undiagnosed SARS-CoV-2 infection.
Lancet Microbe
, 1
(4)
, Article e150. 10.1016/S2666-5247(20)30096-3.
|
|
|
Lechner, M;
Liu, J;
Lund, VJ;
(2020)
Novel Biomarkers in Sinonasal Cancers: from Bench to Bedside.
Current Oncology Reports
, 22
(10)
10.1007/s11912-020-00947-2.
|
|
|
Lechner, M;
Sutton, L;
Murkin, C;
Masterson, L;
O'Flynn, P;
Wareing, MJ;
Tatla, T;
(2020)
Squamous cell cancer of the temporal bone: a review of the literature.
European Archives of Oto-Rhino-Laryngology
10.1007/s00405-020-06281-4.
|
|
|
Ledermann, JA;
Oza, AM;
Lorusso, D;
Aghajanian, C;
Oaknin, A;
Dean, A;
Colombo, N;
... Coleman, RL; + view all
(2020)
Rucaparib for patients with platinum-sensitive, recurrent ovarian carcinoma (ARIEL3): post-progression outcomes and updated safety results from a randomised, placebo-controlled, phase 3 trial.
Lancet Oncology
, 21
(5)
pp. 710-722.
10.1016/S1470-2045(20)30061-9.
|
|
Lee, A;
(2020)
Clinical Portrait of the SARS-CoV-2 Epidemic in European Patients with Cancer.
Cancer Discovery
, 10
(10)
pp. 1465-1474.
10.1158/2159-8290.CD-20-0773.
|
|
Lee, A;
Waterhouse, J;
Linch, M;
(2020)
Changing Paradigms in the Treatment of Advanced Urothelial Carcinoma: A 2020 Update.
EMJ Oncology
, 8
(3)
10.33590/emj/20-00044.
|
|
|
Lee, LYW;
Cazier, J-B;
Starkey, T;
Briggs, SEW;
Arnold, R;
Bisht, V;
Booth, S;
... UK Coronavirus Cancer Monitoring Project Team; + view all
(2020)
COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study.
The Lancet Oncology
, 21
(10)
pp. 1309-1316.
10.1016/S1470-2045(20)30442-3.
|
|
Lee, LYW;
Cazier, JB;
Starkey, T;
Turnbull, CD;
Kerr, R;
Middleton, G;
(2020)
COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study.
The Lancet
, 395
(10241)
pp. 1919-1926.
10.1016/S0140-6736(20)31173-9.
|
|
Lee, RJ;
Khandelwal, G;
Baenke, F;
Cannistraci, A;
Macleod, K;
Mundra, P;
Ashton, G;
... Marais, R; + view all
(2020)
Brain microenvironment-driven resistance to immune and targeted therapies in acral melanoma.
ESMO Open
, 5
(4)
, Article e000707. 10.1136/esmoopen-2020-000707.
|
|
|
Lee, W-C;
Reuben, A;
Hu, X;
McGranahan, N;
Chen, R;
Jalali, A;
Negrao, MV;
... Zhang, J; + view all
(2020)
Multiomics profiling of primary lung cancers and distant metastases reveals immunosuppression as a common characteristic of tumor cells with metastatic plasticity.
Genome Biology
, 21
(1)
, Article 271. 10.1186/s13059-020-02175-0.
|
|
|
Leen, G;
Stein, JE;
Robinson, J;
Maldonado Torres, H;
Marsh, SGE;
(2020)
The HLA diversity of the Anthony Nolan register.
HLA
, 97
(1)
pp. 15-29.
10.1111/tan.14127.
|
|
|
Leon, TE;
Rapoz-D'Silva, T;
Bertoli, C;
Rahman, S;
Magnussen, M;
Philip, B;
Farah, N;
... Mansour, MR; + view all
(2020)
EZH2 deficient T-cell acute lymphoblastic leukemia is sensitized to CHK1 inhibition through enhanced replication stress.
Cancer Discovery
, 10
(7)
10.1158/2159-8290.CD-19-0789.
|
|
Leone, G;
Passiglia, F;
Bironzo, P;
Bertaglia, V;
Novello, S;
(2020)
Is there any place for immune-checkpoint inhibitors in the treatment algorithm of fusion-driven non-small cell lung cancer? -a literature review.
Translational Lung Cancer Research
, 9
(6)
pp. 2674-2685.
10.21037/tlcr-20-710.
|
|
Leong, S;
Inglott, S;
Papaleonidopoulou, F;
Orfinada, K;
Ancliff, P;
Bartram, J;
Carpenter, B;
... O'Connor, D; + view all
(2020)
CD1a is rarely expressed in pediatric or adult relapsed/refractory T-ALL: implications for immunotherapy.
Blood Advances
, 4
(19)
pp. 4665-4668.
10.1182/bloodadvances.2020002502.
|
|
Levine, AP;
Chan, MMY;
Sadeghi-Alavijeh, O;
Wong, EKS;
Cook, HT;
Ashford, S;
Carss, K;
... Gale, DP; + view all
(2020)
Large-Scale Whole-Genome Sequencing Reveals the Genetic Architecture of Primary Membranoproliferative GN and C3 Glomerulopathy.
Journal of the American Society of Nephrology
, 31
(1)
10.1681/ASN.2019040433.
|
|
|
Levitt, JA;
Poland, SP;
Krstajic, N;
Pfisterer, K;
Erdogan, A;
Barber, PR;
Parsons, M;
... Ameer-Beg, SM; + view all
(2020)
Quantitative real-time imaging of intracellular FRET biosensor dynamics using rapid multi-beam confocal FLIM.
Scientific Reports
, 10
, Article 5146. 10.1038/s41598-020-61478-1.
|
|
|
Li, BT;
Michelini, F;
Misale, S;
Cocco, E;
Baldino, L;
Cai, Y;
Shifman, S;
... Scaltriti, M; + view all
(2020)
HER2-Mediated Internalization of Cytotoxic Agents in ERBB2 Amplified or Mutant Lung Cancers.
Cancer Discovery
, 10
(5)
pp. 674-687.
10.1158/2159-8290.cd-20-0215.
|
|
Li, CH;
Prokopec, SD;
Sun, RX;
Yousif, F;
Schmitz, N;
Al-Shahrour, F;
Atwal, G;
... Bader, GD; + view all
(2020)
Sex differences in oncogenic mutational processes.
Nature Communications
, 11
, Article 4330. 10.1038/s41467-020-17359-2.
|
|
|
Lidington, EK;
Smrke, A;
Ingley, KM;
Strauss, SJ;
Husson, O;
Younger, E;
(2020)
Cancer care and well-being in adolescents and young adults during the coronavirus disease 2019 pandemic: A UK sarcoma perspective.
Cancer
, 126
(24)
pp. 5359-5360.
10.1002/cncr.33215.
|
|
Lieverse, RIY;
Van Limbergen, EJ;
Oberije, CJG;
Troost, EGC;
Hadrup, SR;
Dingemans, A-MC;
Hendriks, LEL;
... Lambin, P; + view all
(2020)
Stereotactic ablative body radiotherapy (SABR) combined with immunotherapy (L19-IL2) versus standard of care in stage IV NSCLC patients, ImmunoSABR: a multicentre, randomised controlled open-label phase II trial.
BMC Cancer
, 20
, Article 557. 10.1186/s12885-020-07055-1.
|
|
|
Linch, M;
Lee, A;
(2020)
Positioning checkpoint blockade in urothelial cancer: PURE-01 and PEANUTS.
Annals of Oncology
, 31
(12)
pp. 1601-1602.
10.1016/j.annonc.2020.10.468.
|
|
Linch, D;
(2020)
Developments over the last 60 years in diffuse large B-cell lymphomas.
British Journal of Haematology
, 191
(4)
pp. 552-557.
10.1111/bjh.17154.
|
|
|
Linch, DC;
Hills, RK;
Burnett, AK;
Russell, N;
Gale, RE;
(2020)
Analysis of the clinical impact of NPM1 mutant allele burden in a large cohort of younger adult patients with acute myeloid leukaemia.
British Journal of Haematology
, 188
(6)
pp. 852-859.
10.1111/bjh.16239.
|
|
Linhart, A;
Germain, DP;
Olivotto, I;
Akhtar, MM;
Anastasakis, A;
Hughes, D;
Namdar, M;
... Elliott, P; + view all
(2020)
An Expert Consensus Document on the Management of Cardiovascular Manifestations of Fabry Disease.
European Journal of Heart Failure
, 22
(7)
pp. 1076-1096.
10.1002/ejhf.1960.
|
|
|
Litchfield, K;
Reading, JL;
Lim, EL;
Xu, H;
Liu, P;
Al-Bakir, M;
Wong, YNS;
... Swanton, C; + view all
(2020)
Escape from nonsense-mediated decay associates with anti-tumor immunogenicity.
Nature Communications
, 11
, Article 3800. 10.1038/s41467-020-17526-5.
|
|
|
Litchfield, K;
Stanislaw, S;
Spain, L;
Gallegos, LL;
Rowan, A;
Schnidrig, D;
Rosenbaum, H;
... Turajlic, S; + view all
(2020)
Representative Sequencing: Unbiased Sampling of Solid Tumor Tissue.
Cell Reports
, 31
(5)
p. 107550.
10.1016/j.celrep.2020.107550.
|
|
Liu, MC;
Oxnard, GR;
Klein, EA;
Swanton, C;
Seiden, MV;
CCGA Consortium, .;
(2020)
Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA.
Annals of Oncology
, 31
(6)
pp. 745-759.
10.1016/j.annonc.2020.02.011.
|
|
Loke, J;
Lowe, DM;
Miller, LJ;
Morton, S;
Roy, NBA;
Sekhar, M;
Stanworth, SJ;
(2020)
Supportive care in the management of patients with acute myeloid leukaemia: where are the research needs?
British Journal of Haematology
10.1111/bjh.16708.
(In press).
|
|
|
López, S;
Lim, EL;
Horswell, S;
Haase, K;
Huebner, A;
Dietzen, M;
Mourikis, TP;
... McGranahan, N; + view all
(2020)
Interplay between whole-genome doubling and the accumulation of deleterious alterations in cancer evolution.
Nature Genetics
, 52
(3)
pp. 283-293.
10.1038/s41588-020-0584-7.
|
|
Love, S;
(2020)
Quality of life in the FOXFIRE, SIRFLOX and FOXFIRE‐global randomised trials of selective internal radiotherapy for metastatic colorectal cancer.
International Journal of Cancer
, 147
(4)
pp. 1078-1085.
10.1002/ijc.32828.
|
|
Loveday, C;
Litchfield, K;
Proszek, PZ;
Cornish, AJ;
Santo, F;
Levy, M;
Macintyre, G;
... Turnbull, C; + view all
(2020)
Genomic landscape of platinum resistant and sensitive testicular cancers.
Nature Communications
, 11
, Article 2189. 10.1038/s41467-020-15768-x.
|
|
|
Luong, TV;
Abou-Beih, S;
Watkins, J;
Tsochatzis, E;
Pinzani, M;
Davison, S;
Hall, A;
(2020)
Elastic fibres in alcoholic liver disease.
Scientific Reports
, 10
, Article 20098. 10.1038/s41598-020-77007-z.
|
|
|
Luszczak, S;
Kumar, C;
Sathyadevan, VK;
Simpson, BS;
Gately, KA;
Whitaker, HC;
Heavey, S;
(2020)
PIM kinase inhibition: co-targeted therapeutic approaches in prostate cancer.
Signal Transduction and Targeted Therap
, 5
(1)
, Article 7. 10.1038/s41392-020-0109-y.
|
|
|
Luszczak, S;
Simpson, BS;
Stopka-Farooqui, U;
Sathyadevan, VK;
Echeverria, LMC;
Kumar, C;
Costa, H;
... Heavey, S; + view all
(2020)
Author Correction: Co-targeting PIM and PI3K/mTOR using multikinase inhibitor AUM302 and a combination of AZD-1208 and BEZ235 in prostate cancer.
[Corrigendum].
Scientific Reports
, 10
, Article 19870. 10.1038/s41598-020-76679-x.
|
|
|
Luszczak, S;
Simpson, BS;
Stopka-Farooqui, U;
Sathyadevan, VK;
Echeverria, LMC;
Kumar, C;
Costa, H;
... Heavey, S; + view all
(2020)
Co-targeting PIM and PI3K/mTOR using multikinase inhibitor AUM302 and a combination of AZD-1208 and BEZ235 in prostate cancer.
Scientific Reports
, 10
, Article 14380. 10.1038/s41598-020-71263-9.
|
|
|
Lyons Rimmer, J;
Ercolano, E;
Baiz, D;
Makhija, M;
Berger, A;
Sells, T;
Stroud, S;
... Hanemann, CO; + view all
(2020)
The Potential of MLN3651 in Combination with Selumetinib as a Treatment for Merlin-Deficient Meningioma.
Cancers
, 12
(7)
, Article 1744. 10.3390/cancers12071744.
|
|
|
Lyskjær, I;
Lindsay, D;
Tirabosco, R;
Steele, CD;
Lombard, P;
Strobl, A-C;
Rocha, AM;
... Flanagan, AM; + view all
(2020)
H3K27me3 expression and methylation status in histological variants of malignant peripheral nerve sheath tumours.
The Journal of Pathology
, 252
(2)
pp. 151-164.
10.1002/path.5507.
|
|
|
Mackie, I;
Mancini, I;
Muia, J;
Kremer Hovinga, J;
Nair, S;
Machin, S;
Baker, R;
(2020)
International Council for Standardization in Haematology (ICSH) recommendations for laboratory measurement of ADAMTS13.
International Journal of Laboratory Hematology
, 42
(6)
pp. 685-696.
10.1111/ijlh.13295.
|
|
|
Madsen, RR;
(2020)
PI3K in stemness regulation: from development to cancer.
Biochemical Society Transactions
, 2020
, Article BST20190778. 10.1042/BST20190778.
|
|
|
Madsen, RR;
Vanhaesebroeck, B;
(2020)
Cracking the context-specific PI3K signaling code.
Science Signaling
, 13
(613)
, Article eaay2940. 10.1126/scisignal.aay2940.
|
|
|
Majeed, F;
Yar, T;
Alsunni, AA;
Alhawaj, AF;
Alrahim, AA;
(2020)
Effect of energy drink consumption on baroreceptor sensitivity in young normal weight and overweight/obese males.
Pakistan Journal of Medical Sciences
, 36
(7)
pp. 1590-1595.
10.12669/pjms.36.7.2419.
|
|
|
Mansell, E;
Sigurdsson, V;
Deltcheva, E;
Brown, J;
James, C;
Miharada, K;
Soneji, S;
... Enver, T; + view all
(2020)
Mitochondrial Potentiation Ameliorates Age-Related Heterogeneity in Hematopoietic Stem Cell Function.
Cell Stem Cell
10.1016/j.stem.2020.09.018.
(In press).
|
|
|
Marin, JJG;
Prete, MG;
Lamarca, A;
Tavolari, S;
Landa-Magdalena, A;
Brandi, G;
Segatto, O;
... Braconi, C; + view all
(2020)
Current and novel therapeutic opportunities for systemic therapy in biliary cancer.
British Journal of Cancer
, 123
pp. 1047-1059.
10.1038/s41416-020-0987-3.
|
|
Marshall, A;
Kasturiarachchi, J;
Datta, P;
Guo, Y;
Deltcheva, E;
James, C;
Brown, J;
... Nimmo, R; + view all
(2020)
Mir142 loss unlocks IDH2R140-dependent leukemogenesis through antagonistic regulation of HOX genes.
Scientific Reports
, 10
, Article 19390. 10.1038/s41598-020-76218-8.
|
|
Matharu, RK;
Tabish, TA;
Trakoolwilaiwan, T;
Mansfield, J;
Moger, J;
Wu, T;
Lourenço, C;
... Edirisinghe, M; + view all
(2020)
Microstructure and antibacterial efficacy of graphene oxide nanocomposite fibres.
Journal of Colloid and Interface Science
, 571
pp. 239-252.
10.1016/j.jcis.2020.03.037.
|
|
Mc Lernon, S;
Schwarz, G;
Wilson, D;
Ambler, G;
Goodwin, R;
Shakeshaft, C;
Cohen, H;
... CROMIS-2 Collaborators; + view all
(2020)
Association between critical care admission and 6-month functional outcome after spontaneous intracerebral haemorrhage.
Journal of the Neurological Sciences
, 418
, Article 117141. 10.1016/j.jns.2020.117141.
|
|
McConnell, L;
Houghton, O;
Stewart, P;
Gazdova, J;
Srivastava, S;
Kim, C;
Catherwood, M;
... Gonzalez, D; + view all
(2020)
A novel next generation sequencing approach to improve sarcoma diagnosis.
Modern Pathology
, 33
pp. 1350-1359.
10.1038/s41379-020-0488-1.
|
|
McCourt, O;
Fisher, A;
Ramdharry, G;
Roberts, AL;
Land, J;
Rabin, N;
Yong, K;
(2020)
PERCEPT myeloma: a protocol for a pilot randomised controlled trial of exercise prehabilitation before and during autologous stem cell transplantation in patients with multiple myeloma.
BMJ Open
, 10
(1)
, Article e033176. 10.1136/bmjopen-2019-033176.
|
|
|
McLeavy, L;
Rahman, B;
Kristeleit, R;
Ledermann, J;
Lockley, M;
McCormack, M;
Mould, T;
... Lanceley, A; + view all
(2020)
Mainstreamed Genetic Testing in Ovarian Cancer: Patient Experience of the Testing Process.
International Journal of Gynecological Cancer
, 30
(2)
pp. 221-226.
10.1136/ijgc-2019-000630.
|
|
McMillan, AK;
Phillips, EH;
Kirkwood, AA;
Barrans, S;
Burton, C;
Rule, S;
Patmore, R;
... Linch, DC; + view all
(2020)
Favourable outcomes for high-risk diffuse large B-cell lymphoma (IPI 3–5) treated with front-line R-CODOX-M/R-IVAC chemotherapy: results of a phase 2 UK NCRI trial.
Annals of Oncology
10.1016/j.annonc.2020.05.016.
(In press).
|
|
|
McNamara, MG;
Lopes, A;
Wasan, H;
Malka, D;
Goldstein, D;
Shannon, J;
Okusaka, T;
... Valle, JW; + view all
(2020)
Landmark survival analysis and impact of anatomic origin in prospective clinical trials of biliary tract cancer.
Journal of Hepatology
, 73
(5)
pp. 1109-1117.
10.1016/j.jhep.2020.05.014.
|
|
McVey, JH;
Rallapalli, PM;
Kemball-Cook, G;
Hampshire, DJ;
Giansily-Blaizot, M;
Gomez, K;
Perkins, SJ;
(2020)
The European Association for Haemophilia and Allied Disorders (EAHAD) Coagulation Factor Variant Databases: Important resources for haemostasis clinicians and researchers.
Haemophilia
, 26
(2)
pp. 306-313.
10.1111/hae.13947.
|
|
|
Mehanna, H;
Rischin, D;
Wong, SJ;
Gregoire, V;
Ferris, R;
Waldron, J;
Le, Q-T;
... Porceddu, S; + view all
(2020)
De-Escalation After DE-ESCALATE and RTOG 1016: A Head and Neck Cancer InterGroup Framework for Future De-Escalation Studies.
Journal of Clinical Oncology
, 38
(22)
pp. 2552-2557.
10.1200/JCO.20.00056.
|
|
|
Mehta, A;
Rivero-Arias, O;
Abdelwahab, M;
Campbell, S;
McMillan, A;
Rolfe, MJ;
Bright, JR;
(2020)
Scoring system to facilitate diagnosis of Gaucher disease.
Internal Medicine Journal
, 50
(12)
pp. 1538-1546.
10.1111/imj.14942.
|
|
|
Middleton, G;
Fletcher, P;
Popat, S;
Savage, J;
Summers, Y;
Greystoke, A;
Gilligan, D;
... Billingham, L; + view all
(2020)
The National Lung Matrix Trial of personalized therapy in lung cancer.
Nature
, 583
(7818)
pp. 807-812.
10.1038/s41586-020-2481-8.
|
|
Miles, A;
Evans, RE;
Halligan, S;
Beare, S;
Bridgewater, J;
Goh, V;
Janes, SM;
... STREAMLINE investigators; + view all
(2020)
Predictors of patient preference for either whole body magnetic resonance imaging (WB-MRI) or CT/ PET-CT for staging colorectal or lung cancer.
Journal of Medical Imaging and Radiation Oncology
10.1111/1754-9485.13038.
(In press).
|
|
|
Miller, RE;
Leary, A;
Scott, CL;
Serra, V;
Lord, CJ;
Bowtell, D;
Chang, DK;
... Yates, LR; + view all
(2020)
ESMO recommendations on predictive biomarker testing for homologous recombination deficiency and PARP inhibitor benefit in ovarian cancer.
Annals of Oncology
, 31
(12)
pp. 1606-1622.
10.1016/j.annonc.2020.08.2102.
|
|
|
Miller, DT;
Cortés-Ciriano, I;
Pillay, N;
Hirbe, AC;
Snuderl, M;
Bui, MM;
Piculell, K;
... Flanagan, AM; + view all
(2020)
Genomics of MPNST (GeM) Consortium: Rationale and Study Design for Multi-Omic Characterization of NF1-Associated and Sporadic MPNSTs.
Genes
, 11
(4)
, Article 387. 10.3390/genes11040387.
|
|
|
Mirabello, L;
Zhu, B;
Koster, R;
Karlins, E;
Dean, M;
Yeager, M;
Gianferante, M;
... Savage, SA; + view all
(2020)
Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in Patients With Osteosarcoma.
JAMA Oncology
10.1001/jamaoncol.2020.0197.
(In press).
|
|
Mirza, MR;
Benigno, B;
Dørum, A;
Mahner, S;
Bessette, P;
Barceló, IB;
Berton-Rigaud, D;
... Matulonis, UA; + view all
(2020)
Long-term safety in patients with recurrent ovarian cancer treated with niraparib versus placebo: Results from the phase III ENGOT-OV16/NOVA trial.
Gynecologic Oncology
10.1016/j.ygyno.2020.09.006.
(In press).
|
|
|
Mitchell, E;
Goodman, K;
Hartley, S;
Hickey, H;
McDonald, AM;
Meadows, HM;
Rhodes, S;
... UK Trial Managers’ Network Executive Group; + view all
(2020)
Where do we go from here? – Opportunities and barriers to the career development of trial managers: a survey of UK-based trial management professionals.
Trials
, 21
, Article 384. 10.1186/s13063-020-04316-z.
|
|
|
Montagner, M;
Bhome, R;
Hooper, S;
Chakravarty, P;
Qin, X;
Sufi, J;
Bhargava, A;
... Sahai, E; + view all
(2020)
Crosstalk with lung epithelial cells regulates Sfrp2-mediated latency in breast cancer dissemination.
Nature Cell Biology
, 22
pp. 289-296.
10.1038/s41556-020-0474-3.
|
|
Moore, KM;
Desai, A;
Delgado, BDL;
Trabulo, SMD;
Reader, C;
Brown, NF;
Murray, ER;
... Marshall, JF; + view all
(2020)
Integrin αvβ6-specific therapy for pancreatic cancer developed from foot-and-mouth-disease virus.
Theranostics
, 10
(7)
pp. 2930-2942.
10.7150/thno.38702.
|
|
|
Moorman, AV;
Schwab, C;
Winterman, E;
Hancock, J;
Castleton, A;
Cummins, M;
Gibson, B;
... Vora, A; + view all
(2020)
Adjuvant tyrosine kinase inhibitor therapy improves outcome for children and adolescents with acute lymphoblastic leukaemia who have an ABL‐class fusion.
British Journal of Haematology
10.1111/bjh.17093.
(In press).
|
|
|
Morales Torres, C;
Wu, MY;
Hobor, S;
Wainwright, EN;
Martin, MJ;
Patel, H;
Grey, W;
... Scaffidi, P; + view all
(2020)
Selective inhibition of cancer cell self-renewal through a Quisinostat-histone H1.0 axis.
Nature Communications
, 11
(1)
, Article 1792. 10.1038/s41467-020-15615-z.
|
|
|
Moreau, P;
Dimopoulos, MA;
Yong, K;
Mikhael, J;
Risse, M-L;
Asset, G;
Martin, T;
(2020)
Isatuximab plus carfilzomib/dexamethasone versus carfilzomib/dexamethasone in patients with relapsed/refractory multiple myeloma: IKEMA Phase III study design.
Future Oncology
, 16
(2)
pp. 4347-4358.
10.2217/fon-2019-0431.
|
|
|
Morschhauser, F;
Machiels, J-P;
Salles, G;
Rottey, S;
Rule, SAJ;
Cunningham, D;
Peyrade, F;
... Awada, A; + view all
(2020)
On-Target Pharmacodynamic Activity of the PI3K Inhibitor Copanlisib in Paired Biopsies from Patients with Malignant Lymphoma and Advanced Solid Tumors.
Molecular Cancer Therapeutics
, 19
(2)
pp. 468-478.
10.1158/1535-7163.MCT-19-0466.
|
|
Mullin, S;
Stokholm, MG;
Hughes, D;
Mehta, A;
Parbo, P;
Hinz, R;
Pavese, N;
... Schapira, AH; + view all
(2020)
Brain Microglial Activation Increased in Glucocerebrosidase (GBA) Mutation Carriers without Parkinson's disease.
Movement Disorders
10.1002/mds.28375.
|
|
|
Munkhbaatar, E;
Dietzen, M;
Agrawal, D;
Anton, M;
Jesinghaus, M;
Boxberg, M;
Pfarr, N;
... Jost, PJ; + view all
(2020)
MCL-1 gains occur with high frequency in lung adenocarcinoma and can be targeted therapeutically.
Nature Communications
, 11
(1)
, Article 4527. 10.1038/s41467-020-18372-1.
|
|
|
Nannini, F;
Parekh, F;
Wawrzyniecka, P;
Mekkaoui, L;
Righi, M;
Dastjerdi, FV;
Yeung, J;
... Pule, M; + view all
(2020)
A primer set for the rapid isolation of scFv fragments against cell surface antigens from immunised rats.
Scientific Reports
, 10
, Article 19168. 10.1038/s41598-020-76069-3.
|
|
|
Nathwani, AC;
Tuddenham, EGD;
(2020)
Haemophilia, the journey in search of a cure. 1960–2020.
British Journal of Haematology
, 191
(4)
pp. 573-578.
10.1111/bjh.17155.
|
|
Newton, C;
Nordin, A;
Rolland, P;
Ind, T;
Larsen-Disney, P;
Martin-Hirsch, P;
Beaver, K;
... Fotopoulou, C; + view all
(2020)
British Gynaecological Cancer Society recommendations and guidance on patient-initiated follow-up (PIFU).
International Journal of Gynecologic Cancer
, 30
(5)
pp. 695-700.
10.1136/ijgc-2019-001176.
|
|
|
Ng, K;
Smith, S;
Shamash, J;
(2020)
Metastatic Hormone-Sensitive Prostate Cancer (mHSPC): Advances and Treatment Strategies in the First-Line Setting.
Oncology and Therapy
10.1007/s40487-020-00119-z.
(In press).
|
|
|
Ng, KW;
Faulkner, N;
Cornish, GH;
Rosa, A;
Harvey, R;
Hussain, S;
Ulferts, R;
... Kassiotis, G; + view all
(2020)
Preexisting and de novo humoral immunity to SARS-CoV-2 in humans.
Science
, Article eabe1107. 10.1126/science.abe1107.
(In press).
|
|
|
Nordstrom, BL;
Oguz, M;
Chu, BC;
Ouwens, M;
Arkenau, H-T;
Klein, AB;
(2020)
Effectiveness of durvalumab versus chemotherapy in metastatic urothelial cancer: an observational, indirect comparison.
Journal of Comparative Effectiveness Research
, 9
(3)
pp. 191-199.
10.2217/cer-2019-0163.
|
|
|
Norris, JM;
Carmona Echeverria, LM;
Simpson, BS;
Allen, C;
Ball, R;
Freeman, A;
Kelly, D;
... Emberton, M; + view all
(2020)
Prostate Cancer Visibility on Multiparametric Magnetic Resonance Imaging: High Gleason Grade and Increased Tumour Volume are Not the Only Important Histopathological Features.
BJU International
, 126
(2)
pp. 237-239.
10.1111/bju.15085.
|
|
Norris, JM;
Carmona Echeverria, LM;
Simpson, BS;
Ball, R;
Freeman, A;
Kelly, D;
Kirkham, A;
... Emberton, M; + view all
(2020)
Histopathological features of prostate cancer conspicuity on multiparametric MRI: protocol for a systematic review and meta-analysis.
BMJ Open
, 10
(10)
, Article e039735. 10.1136/bmjopen-2020-039735.
|
|
|
Norris, JM;
Simpson, BS;
Freeman, A;
Kirkham, A;
Whitaker, HC;
Emberton, M;
(2020)
Conspicuity of prostate cancer on multiparametric magnetic resonance imaging: A cross-disciplinary translational hypothesis.
The FASEB Journal
, 34
pp. 14150-14159.
10.1096/fj.202001466R.
|
|
|
Norris, JM;
Simpson, BS;
Parry, MA;
Allen, C;
Ball, R;
Freeman, A;
Kelly, D;
... Emberton, M; + view all
(2020)
Genetic Landscape of Prostate Cancer Conspicuity on Multiparametric Magnetic Resonance Imaging: A Systematic Review and Bioinformatic Analysis.
European Urology Open Science
, 20
pp. 37-47.
10.1016/j.euros.2020.06.006.
|
|
|
Norris, JM;
Simpson, BS;
Parry, MA;
Allen, C;
Ball, R;
Freeman, A;
Kelly, D;
... Emberton, M; + view all
(2020)
Genetic landscape of prostate cancer conspicuity on multiparametric MRI: a protocol for a systematic review and bioinformatic analysis.
BMJ Open
, 10
(1)
, Article e034611. 10.1136/bmjopen-2019-034611.
|
|
|
Norris, JM;
Simpson, BS;
Parry, MA;
Kasivisvanathan, V;
Allen, C;
Ball, R;
Freeman, A;
... Emberton, M; + view all
(2020)
Genetic correlates of prostate cancer visibility (and invisibility) on mpMRI: It's time to take stock.
BJU International
, 125
(3)
pp. 340-342.
10.1111/bju.14919.
|
|
Nowosad, A;
Besson, A;
(2020)
CDKN1B/p27 regulates autophagy via the control of Ragulator and MTOR activity in amino acid-deprived cells.
Autophagy
, 16
(12)
pp. 2297-2298.
10.1080/15548627.2020.1831217.
|
|
O'Connor, E;
Simpson, BS;
Houlden, H;
Vandrovcova, J;
Matharu, M;
(2020)
Prevalence of familial cluster headache: a systematic review and meta-analysis.
The Journal of Headache and Pain
, 21
, Article 37. 10.1186/s10194-020-01101-w.
|
|
|
O'Donnell, PH;
Arkenau, HT;
Sridhar, SS;
Ong, M;
Drakaki, A;
Spira, A;
Zhang, J;
... Friedlander, T; + view all
(2020)
Patient‐reported outcomes and inflammatory biomarkers in patients with locally advanced/metastatic urothelial carcinoma treated with durvalumab in phase 1/2 dose‐escalation study 1108.
Cancer
, 126
(2)
pp. 432-443.
10.1002/cncr.32532.
|
|
Ogunlade, O;
Stowe, C;
Jathoul, A;
Kalber, T;
Lythgoe, MF;
Beard, P;
Pule, M;
(2020)
In vivo photoacoustic imaging of a nonfluorescent E2 crimson genetic reporter in mammalian tissues.
Journal of Biomedical Optics
, 25
(04)
, Article 046004. 10.1117/1.jbo.25.4.046004.
|
|
|
Oka, A;
Takagi, A;
Komiyama, E;
Yoshihara, N;
Mano, S;
Hosomichi, K;
Suzuki, S;
... Ikeda, S; + view all
(2020)
Alopecia areata susceptibility variant in MHC region impacts expressions of genes contributing to hair keratinization and is involved in hair loss.
EBioMedicine
, 57
, Article 102810. 10.1016/j.ebiom.2020.102810.
|
|
|
Orf, K;
Rogosic, S;
Dexter, D;
Ancliff, P;
Badle, S;
Brierley, J;
Cheng, D;
... Bartram, J; + view all
(2020)
Remdesivir during induction chemotherapy for newly diagnosed paediatric acute lymphoblastic leukaemia with concomitant SARS-CoV-2 infection.
British Journal of Haematology
, 190
(5)
E274-E276.
10.1111/bjh.17014.
|
|
Orgaz, JL;
Crosas-Molist, E;
Sadok, A;
Perdrix-Rosell, A;
Maiques, O;
Rodriguez-Hernandez, I;
Monger, J;
... Sanz-Moreno, V; + view all
(2020)
Myosin II Reactivation and Cytoskeletal Remodeling as a Hallmark and a Vulnerability in Melanoma Therapy Resistance.
Cancer Cell
, 37
(1)
85-103.e9.
10.1016/j.ccell.2019.12.003.
|
|
|
Oza, AM;
Lorusso, D;
Aghajanian, C;
Oaknin, A;
Dean, A;
Colombo, N;
Weberpals, JI;
... Coleman, RL; + view all
(2020)
Patient-Centered Outcomes in ARIEL3, a Phase III, Randomized, Placebo-Controlled Trial of Rucaparib Maintenance Treatment in Patients With Recurrent Ovarian Carcinoma.
Journal of Clinical Oncology
10.1200/JCO.19.03107.
(In press).
|
 |
|
Oza, AM;
Matulonis, UA;
Alvarez Secord, A;
Nemunaitis, J;
Roman, LD;
Blagden, SP;
Banerjee, S;
... Matei, D; + view all
(2020)
A Randomized Phase II Trial of Epigenetic Priming with Guadecitabine and Carboplatin in Platinum-resistant, Recurrent Ovarian Cancer.
Clinical Cancer Research
, 26
(5)
pp. 1009-1016.
10.1158/1078-0432.CCR-19-1638.
|
|
Palomo-Irigoyen, M;
Pérez-Andrés, E;
Iruarrizaga-Lejarreta, M;
Barreira Manrique, A;
Tamayo-Caro, M;
Vila-Vecilla, L;
Moreno-Cugnon, L;
... Woodhoo, A; + view all
(2020)
HuR/ELAVL1 drives malignant peripheral nerve sheath tumour growth and metastasis.
Journal of Clinical Investigation
10.1172/JCI130379.
(In press).
|
|
|
Paradee, N;
Utama-Ang, N;
Uthaipibull, C;
Porter, JB;
Garbowski, MW;
Srichairatanakool, S;
(2020)
Extracts of Thai Perilla frutescens nutlets attenuate tumour necrosis factor-α-activated generation of microparticles, ICAM-1 and IL-6 in human endothelial cells.
Bioscience Reports
, 40
(5)
, Article BSR20192110. 10.1042/BSR20192110.
|
|
|
Parhizkar, M;
Reardon, PJT;
Harker, AH;
Browning, RJ;
Stride, E;
Pedley, RB;
Knowles, JC;
(2020)
Enhanced efficacy in drug-resistant cancer cells through synergistic nanoparticle mediated delivery of cisplatin and decitabine.
Nanoscale Advances
10.1039/c9na00684b.
(In press).
|
|
|
Pastores, GM;
Hughes, DA;
(2020)
Lysosomal Acid Lipase Deficiency: Therapeutic Options.
Drug Design, Development and Therapy
, 2020
(14)
pp. 591-601.
10.2147/DDDT.S149264.
|
|
|
Patel, P;
Alrifai, D;
McDonald, F;
Forster, M;
(2020)
Beyond chemoradiotherapy: improving treatment outcomes for patients with stage III unresectable non-small-cell lung cancer through immuno-oncology and durvalumab (Imfinzi®▼, AstraZeneca UK Limited).
British Journal of Cancer
, 123
pp. 18-27.
10.1038/s41416-020-01071-5.
|
|
|
Patrick, PS;
Kolluri, KK;
Zaw Thin, M;
Edwards, A;
Sage, EK;
Sanderson, T;
Weil, BD;
... Kalber, TL; + view all
(2020)
Lung delivery of MSCs expressing anti-cancer protein TRAIL visualised with ⁸⁹Zr-oxine PET-CT.
Stem Cell Research & Therapy
, 11
, Article 256. 10.1186/s13287-020-01770-z.
|
|
|
Pennycuick, A;
Teixeira, VH;
AbdulJabbar, K;
Raza, SEA;
Lund, T;
Akarca, AU;
Rosenthal, R;
... Janes, SM; + view all
(2020)
Immune surveillance in clinical regression of pre-invasive squamous cell lung cancer.
Cancer Discovery
, 10
(10)
pp. 1489-1499.
10.1158/2159-8290.CD-19-1366.
|
|
Perez-Gracia, JL;
Awada, A;
Calvo, E;
Amaral, T;
Arkenau, H-T;
Gruenwald, V;
Bodoky, G;
... Douillard, J-Y; + view all
(2020)
ESMO Clinical Research Observatory (ECRO): improving the efficiency of clinical research through rationalisation of bureaucracy.
ESMO Open
, 5
(3)
, Article e000662. 10.1136/esmoopen-2019-000662.
|
|
|
Perry, N;
Moss, S;
Dixon, S;
Milner, S;
Mokbel, K;
Lemech, C;
Arkenau, H-T;
... Pinker, K; + view all
(2020)
Mammographic Breast Density and Urbanization: Interactions with BMI, Environmental, Lifestyle, and Other Patient Factors.
Diagnostics
, 10
(6)
, Article 418. 10.3390/diagnostics10060418.
|
|
|
Pettitt, SJ;
Frankum, JR;
Punta, M;
Lise, S;
Alexander, J;
Chen, Y;
Yap, TA;
... Lord, CJ; + view all
(2020)
Clinical brca1/2 reversion analysis identifies hotspot mutations and predicted neoantigens associated with therapy resistance.
Cancer Discovery
, 10
(10)
pp. 1475-1488.
10.1158/2159-8290.CD-19-1485.
|
|
Pickles, OJ;
Lee, LYW;
Starkey, T;
Freeman-Mills, L;
Olsson-Brown, A;
Cheng, V;
Hughes, DJ;
... Middleton, G; + view all
(2020)
Immune checkpoint blockade: releasing the breaks or a protective barrier to COVID-19 severe acute respiratory syndrome?
British Journal of Cancer
, 123
pp. 691-693.
10.1038/s41416-020-0930-7.
|
|
Pilotti, C;
Greenwood, J;
Moss, SE;
(2020)
Functional Evaluation of AMD-Associated Risk Variants of Complement Factor B.
Investigative Opthalmology & Visual Science
, 61
(5)
, Article 19. 10.1167/iovs.61.5.19.
|
|
|
Pinato, DJ;
Lee, AJX;
Biello, F;
Seguí, E;
Aguilar-Company, J;
Carbó, A;
Bruna, R;
... Gennari, A; + view all
(2020)
Presenting Features and Early Mortality from SARS-CoV-2 Infection in Cancer Patients during the Initial Stage of the COVID-19 Pandemic in Europe.
Cancers
, 12
(7)
, Article 1841. 10.3390/cancers12071841.
|
|
|
Pontikos, N;
Murphy, C;
Moghul, I;
Arno, G;
Fujinami, K;
Fujinami, Y;
Sumodhee, D;
... UK Inherited Retinal Dystrophy Consortium, Phenopolis Consortium; + view all
(2020)
Phenogenon: Gene to phenotype associations for rare genetic diseases.
PLOS ONE
, 15
(4)
, Article e0230587. 10.1371/journal.pone.0230587.
|
|
|
Popat, R;
Warcel, D;
O'Nions, J;
Cowley, A;
Smith, S;
Tucker, WR;
Yong, K;
(2020)
Characterization of response and corneal events with extended follow-up after belantamab mafodotin (GSK2857916) monotherapy for patients with relapsed multiple myeloma: a case series from the first-time-in-human clinical trial.
Haematologica
, 105
(5)
E261-E263.
10.3324/haematol.2019.235937.
|
|
|
Porter, JB;
(2020)
Iron Through the Prism of Haematology.
British Journal of Haematology
, 191
(4)
pp. 587-592.
10.1111/bjh.17164.
|
|
|
Prendergast, SC;
Strobl, A-C;
Cross, W;
Pillay, N;
Strauss, SJ;
Ye, H;
Lindsay, D;
... Amary, F; + view all
(2020)
Sarcoma and the 100,000 Genomes Project: our experience and changes to practice.
The Journal of Pathology: Clinical Research
10.1002/cjp2.174.
(In press).
|
|
|
Pressney, I;
Khoo, M;
Endozo, R;
Ganeshan, B;
O'Donnell, P;
(2020)
Pilot study to differentiate lipoma from atypical lipomatous tumour/well-differentiated liposarcoma using MR radiomics-based texture analysis.
Skeletal Radiology
, 49
pp. 1719-1729.
10.1007/s00256-020-03454-4.
|
|
Prommaban, A;
Utama-Ang, N;
Chaikitwattana, A;
Uthaipibull, C;
Porter, JB;
Srichairatanakool, S;
(2020)
Phytosterol, Lipid and Phenolic Composition, and Biological Activities of Guava Seed Oil.
Molecules
, 25
(11)
, Article 2474. 10.3390/molecules25112474.
|
|
|
Przewrocka, J;
Rowan, A;
Rosenthal, R;
Kanu, N;
Swanton, C;
(2020)
Unintended on-target chromosomal instability following CRISPR/Cas9 single gene targeting.
Annals of Oncology
, 31
(9)
pp. 1270-1273.
10.1016/j.annonc.2020.04.480.
|
|
Pugh, G;
Petrella, A;
Pabary, A;
Cross, A;
Hough, R;
Soanes, L;
Sabiston, C;
(2020)
Health Professionals' Views on Lifestyle Advice Delivery to Teenage and Young Adult Cancer Patients: A Qualitative Study.
Cancer Nursing
10.1097/NCC.0000000000000906.
(In press).
|
|
Qin, X;
Tape, CJ;
(2020)
Deciphering Organoids: High-Dimensional Analysis of Biomimetic Cultures.
Trends in Biotechnology
, 39
(8)
pp. 774-787.
10.1016/j.tibtech.2020.10.013.
|
|
Qin, X;
Sufi, J;
Vlckova, P;
Kyriakidou, P;
Acton, SE;
Li, VSW;
Nitz, M;
(2020)
Cell-type-specific signaling networks in heterocellular organoids.
Nature Methods
, 17
pp. 335-342.
10.1038/s41592-020-0737-8.
|
|
Rao, S;
Sclafani, F;
Eng, C;
Adams, RA;
Guren, MG;
Sebag-Montefiore, D;
Benson, A;
... Cunningham, D; + view all
(2020)
International Rare Cancers Initiative Multicenter Randomized Phase II Trial of Cisplatin and Fluorouracil Versus Carboplatin and Paclitaxel in Advanced Anal Cancer: InterAAct.
Journal of Clinical Oncology
, 38
(22)
pp. 2510-2518.
10.1200/JCO.19.03266.
|
|
Reale, ML;
Bironzo, P;
Bertaglia, V;
Palesandro, E;
Leone, G;
Tabbò, F;
Bungaro, M;
... Novello, S; + view all
(2020)
SARS-CoV-2 Infection in Cancer Patients: A Picture of an Italian Onco-Covid Unit.
Frontiers in Oncology
, 10
, Article 1722. 10.3389/fonc.2020.01722.
|
|
Rio-Machin, A;
Vulliamy, T;
Hug, N;
Walne, A;
Tawana, K;
Cardoso, S;
Ellison, A;
... Dokal, I; + view all
(2020)
The complex genetic landscape of familial MDS and AML reveals pathogenic germline variants.
Nature Communications
, 11
, Article 1044. 10.1038/s41467-020-14829-5.
|
|
|
Robertson, NJ;
Meehan, C;
Martinello, KA;
Avdic-Belltheus, A;
Boggini, T;
Mutshiya, T;
Lingam, I;
... Lowdell, MW; + view all
(2020)
Human umbilical cord mesenchymal stromal cells as an adjunct therapy with therapeutic hypothermia in a piglet model of perinatal asphyxia.
Cytotherapy
10.1016/j.jcyt.2020.10.005.
(In press).
|
|
|
Rodríguez-Galán, O;
García-Gómez, JJ;
Rosado, IV;
Wei, W;
Méndez-Godoy, A;
Pillet, B;
Alekseenko, A;
... de la Cruz, J; + view all
(2020)
A functional connection between translation elongation and protein folding at the ribosome exit tunnel in Saccharomyces cerevisiae.
Nucleic Acids Research
10.1093/nar/gkaa1200.
(In press).
|
|
|
Rodríguez-Martínez, M;
Boissiére, T;
Gonzalez, MN;
Litchfield, K;
Mitter, R;
Walker, J;
Kjœr, S;
... Svejstrup, JQ; + view all
(2020)
Evidence That STK19 Is Not an NRAS-dependent Melanoma Driver.
Cell
, 181
(6)
1395-1405.e11.
10.1016/j.cell.2020.04.014.
|
|
|
Roe, J;
Venturini, C;
Gupta, R;
Gurry, C;
Chain, BM;
Sun, Y;
Southern, J;
... Noursadeghi, M; + view all
(2020)
Blood transcriptomic stratification of short-term risk in contacts of tuberculosis.
Clinical Infectious Diseases
, 70
(5)
pp. 731-737.
10.1093/cid/ciz252.
|
|
Roncolato, FT;
O'Connell, R;
Joly, F;
Lanceley, A;
Hilpert, L;
Buizen, L;
Okamoto, E;
... Friedlander, ML; + view all
(2020)
Predictors of progression free survival, overall survival and early cessation of chemotherapy in women with potentially platinum sensitive (PPS) recurrent ovarian cancer (ROC) starting third or subsequent line(> 3) chemotherapy – the GCIG Symptom Benefit Study (SBS).
Gynecologic Oncology
, 156
(1)
pp. 45-53.
10.1016/j.ygyno.2019.10.001.
|
|
Rosenfeld, A;
Graham, DG;
Jevons, S;
Ariza, J;
Hagan, D;
Wilson, A;
Lovat, SJ;
... Cave, S; + view all
(2020)
Development and validation of a risk prediction model to diagnose Barrett's oesophagus (MARK-BE): a case-control machine learning approach.
The Lancet Digital Health
, 2
(1)
e37-e48.
10.1016/S2589-7500(19)30216-X.
|
|
|
Sabbah, S;
Liew, A;
Brooks, AM;
Kundu, R;
Reading, JL;
Flatt, A;
Counter, C;
... Tree, TIM; + view all
(2020)
Autoreactive T cell profiles are altered following allogeneic islet transplantation with alemtuzumab induction and re‐emerging phenotype is associated with graft function.
American Journal of Transplantation
10.1111/ajt.16285.
(In press).
|
|
|
Sabry, M;
Lowdell, MW;
(2020)
Killers at the crossroads: The use of innate immune cells in adoptive cellular therapy of cancer.
Stem Cells Translational Medicine
10.1002/sctm.19-0423.
(In press).
|
|
|
Sadeqi Azer, E;
Rashidi Mehrabadi, F;
Malikić, S;
Li, XC;
Bartok, O;
Litchfield, K;
Levy, R;
... Sahinalp, SC; + view all
(2020)
PhISCS-BnB: a fast branch and bound algorithm for the perfect tumor phylogeny reconstruction problem.
Bioinformatics
, 36
(S1)
i169-i176.
10.1093/bioinformatics/btaa464.
|
|
Sangro, B;
Chan, SL;
Meyer, T;
Reig, M;
El-Khoueiry, A;
Galle, PR;
(2020)
Diagnosis and management of toxicities of immune checkpoint inhibitors in hepatocellular carcinoma.
Journal of Hepatology
, 72
(2)
pp. 320-341.
10.1016/j.jhep.2019.10.021.
|
|
Sarker, D;
Plummer, R;
Meyer, T;
Sodergren, M;
Basu, B;
Chee, CE;
Huang, K-W;
... Habib, N; + view all
(2020)
MTL-CEBPA, a Small Activating RNA Therapeutic Upregulating C/EBP-α, in Patients with Advanced Liver Cancer: A First-in-Human, Multicenter, Open-Label, Phase I Trial.
Clinical Cancer Research
, 26
(15)
pp. 3936-3946.
10.1158/1078-0432.CCR-20-0414.
|
|
Schenk, A;
López, S;
Kschischo, M;
McGranahan, N;
(2020)
Germline ancestry influences the evolutionary disease course in lung adenocarcinomas.
Evolutionary Applications
10.1111/eva.12964.
|
|
|
Schmid, P;
Abraham, J;
Chan, S;
Wheatley, D;
Brunt, AM;
Nemsadze, G;
Baird, RD;
... Turner, NC; + view all
(2020)
Capivasertib Plus Paclitaxel Versus Placebo Plus Paclitaxel As First-Line Therapy for Metastatic Triple-Negative Breast Cancer: The PAKT Trial.
Journal of Clinical Oncology
, 38
(5)
pp. 423-433.
10.1200/JCO.19.00368.
|
|
Schneider, P;
Walters, WP;
Plowright, AT;
Sieroka, N;
Listgarten, J;
Goodnow, RA;
Fisher, J;
... Schneider, G; + view all
(2020)
Rethinking drug design in the artificial intelligence era.
Nature Reviews Drug Discovery
, 19
pp. 353-364.
10.1038/s41573-019-0050-3.
|
|
Schreiber, K;
Sciascia, S;
Bruce, IN;
Giles, I;
Cuadrado, MJ;
Cohen, H;
Gordon, C;
... Hunt, BJ; + view all
(2020)
Hydroxychloroquine in patients with rheumatic diseases during the COVID-19 pandemic: a letter to clinicians.
The Lancet Rheumatology
10.1016/S2665-9913(20)30382-9.
(In press).
|
|
|
Sekhar, M;
Jadhav, S;
(2020)
Why stay? Resilience in haemophilia physicians in the 1980s.
Haemophilia
, 26
(3)
pp. 401-408.
10.1111/hae.13967.
|
|
Shafat, MS;
Mehra, V;
Peggs, KS;
Roddie, C;
(2020)
Cellular Therapeutic Approaches to Cytomegalovirus Infection Following Allogeneic Stem Cell Transplantation.
Frontiers in Immunology
, 11
, Article 1694. 10.3389/fimmu.2020.01694.
|
|
|
Shah, V;
Sherborne, AL;
Johnson, DC;
Ellis, S;
Price, A;
Chowdhury, F;
Kendall, J;
... on behalf of NCRI Haematology Clinical Studies Group; + view all
(2020)
Predicting ultrahigh risk multiple myeloma by molecular profiling:
an analysis of newly diagnosed transplant eligible myeloma XI trial
patients.
Leukemia
10.1038/s41375-020-0750-z.
|
|
|
Sharpley, FA;
De-Silva, D;
Mahmood, S;
Sachchithanantham, S;
Ramsay, I;
Garcia Mingo, A;
Worthington, S;
... D Wechalekar, A; + view all
(2020)
Cytomegalovirus reactivation after bortezomib treatment for multiple myeloma and light chain amyloidosis.
European Journal of Haematology
, 104
(3)
pp. 230-235.
10.1111/ejh.13366.
|
|
Sia, KC;
Fu, ZY;
Calne, RY;
Nathwani, AC;
Lee, KO;
Gan, SU;
(2020)
Modification of a Constitutive to Glucose-Responsive Liver-Specific Promoter Resulted in Increased Efficacy of Adeno-Associated Virus Serotype 8-Insulin Gene Therapy of Diabetic Mice.
Cells
, 9
(11)
, Article 2474. 10.3390/cells9112474.
|
|
|
Sil, BC;
Belgrave, RG;
Alvarez, MP;
Luo, L;
Cristofoli, M;
Penny, MR;
Moore, DJ;
... Hilton, ST; + view all
(2020)
3D Printed Franz cells - update on optimization of manufacture and evaluation.
International Journal of Cosmetic Science
10.1111/ics.12618.
(In press).
|
|
|
Silvestre Patallo, I;
Subiel, A;
Westhorpe, A;
Gouldstone, C;
Tulk, A;
Sharma, RA;
Schettino, G;
(2020)
Development and Implementation of an End-To-End Test for Absolute Dose Verification of Small Animal Preclinical Irradiation Research Platforms.
International Journal of Radiation Oncology*Biology*Physics
, 107
(3)
pp. 587-596.
10.1016/j.ijrobp.2020.03.001.
|
|
Simpson, BS;
Camacho, N;
Luxton, HJ;
Pye, H;
Finn, R;
Heavey, S;
Pitt, J;
... Whitaker, HC; + view all
(2020)
Genetic alterations in the 3q26.31-32 locus confer an aggressive prostate cancer phenotype.
Communications Biology
, 3
(1)
, Article 440. 10.1038/s42003-020-01175-x.
|
|
|
Śledzińska, A;
Vila de Mucha, M;
Bergerhoff, K;
Hotblack, A;
Demane, DF;
Ghorani, E;
Akarca, AU;
... Quezada, SA; + view all
(2020)
Regulatory T Cells Restrain Interleukin-2- and Blimp-1-Dependent Acquisition of Cytotoxic Function by CD4⁺ T Cells.
Immunity
, 52
(1)
151-166.e6.
10.1016/j.immuni.2019.12.007.
|
|
Slyper, M;
Porter, CBM;
Ashenberg, O;
Waldman, J;
Drokhlyansky, E;
Wakiro, I;
Smillie, C;
... Regev, A; + view all
(2020)
A single-cell and single-nucleus RNA-Seq toolbox for fresh and frozen human tumors.
Nature Medicine
, 26
pp. 792-802.
10.1038/s41591-020-0844-1.
|
|
|
Słabicki, M;
Kozicka, Z;
Petzold, G;
Li, Y-D;
Manojkumar, M;
Bunker, RD;
Donovan, KA;
... Ebert, BL; + view all
(2020)
The CDK inhibitor CR8 acts as a molecular glue degrader that depletes cyclin K.
Nature
, 585
(7824)
pp. 293-297.
10.1038/s41586-020-2374-x.
|
|
Sng, CCT;
Wong, YNS;
Wu, A;
Ottaviani, D;
Chopra, N;
Galazi, M;
Benafif, S;
... Shaw, H; + view all
(2020)
Cancer History and Systemic Anti-Cancer Therapy Independently Predict COVID-19 Mortality: A UK Tertiary Hospital Experience.
Frontiers in Oncology
, 10
, Article 595804. 10.3389/fonc.2020.595804.
|
|
|
Solomon, I;
Amann, M;
Goubier, A;
Vargas, FA;
Zervas, D;
Qing, C;
Henry, JY;
... Quezada, SA; + view all
(2020)
CD25-Treg-depleting antibodies preserving IL-2 signaling on effector T cells enhance effector activation and antitumor immunity.
Nature Cancer
, 1
(12)
pp. 1153-1166.
10.1038/s43018-020-00133-0.
|
|
|
Stark, A-K;
Davenport, ECM;
Patton, DT;
Scudamore, CL;
Vanhaesebroeck, B;
Veldhoen, M;
Garden, OA;
(2020)
Loss of Phosphatidylinositol 3-Kinase Activity in Regulatory T Cells Leads to Neuronal Inflammation.
The Journal of Immunology
10.4049/jimmunol.2000043.
(In press).
|
|
|
Stavish, D;
Böiers, C;
Price, C;
Frith, TJR;
Halliwell, J;
Saldaña-Guerrero, I;
Wray, J;
... Enver, T; + view all
(2020)
Generation and trapping of a mesoderm biased state of human pluripotency.
Nature Communications
, 11
, Article 4989. 10.1038/s41467-020-18727-8.
|
|
|
Steele, CD;
Pillay, N;
(2020)
The genomics of undifferentiated sarcoma of soft tissue: Progress, challenges and opportunities.
Seminars in Cancer Biology
, 61
pp. 42-55.
10.1016/j.semcancer.2019.11.009.
|
|
Straathof, K;
Flutter, B;
Wallace, R;
Jain, N;
Loka, T;
Depani, S;
Wright, G;
... Anderson, J; + view all
(2020)
Anti-tumor activity without on-target off-tumor toxicity of GD2-Chimeric Antigen Receptor T cells in patients with neuroblastoma.
Science Translational Medicine
, 12
(571)
, Article eabd6169. 10.1126/scitranslmed.abd6169.
|
|
Sud, A;
Jones, M;
Broggio, J;
Loveday, C;
Torr, B;
Garrett, A;
Nicol, DL;
... Turnbull, C; + view all
(2020)
Collateral damage: the impact on outcomes from cancer surgery of the COVID-19 pandemic.
Annals of Oncology
10.1016/j.annonc.2020.05.009.
(In press).
|
|
|
Sud, A;
Torr, B;
Jones, ME;
Broggio, J;
Scott, S;
Loveday, C;
Garrett, A;
... Turnbull, C; + view all
(2020)
Effect of delays in the 2-week-wait cancer referral pathway during the COVID-19 pandemic on cancer survival in the UK: a modelling study.
The Lancet Oncology
, 21
(8)
pp. 1035-1044.
10.1016/S1470-2045(20)30392-2.
|
|
|
Sullivan, S;
Fairchild, PJ;
Marsh, SGE;
Mueller, CR;
Turner, ML;
Song, J;
Turner, D;
(2020)
Haplobanking induced pluripotent stem cells for clinical use.
Stem Cell Research
, 49
, Article 102035. 10.1016/j.scr.2020.102035.
|
|
|
Sullivan, R;
Heavey, S;
Graham, DG;
Wellman, R;
Khan, S;
Thrumurthy, S;
Simpson, BS;
... Lovat, LB; + view all
(2020)
An optimised saliva collection method to produce high-yield, high-quality RNA for translational research.
PLOS ONE
, 15
(3)
, Article e0229791. 10.1371/journal.pone.0229791.
|
|
|
Sun, Xi-Ming;
Bowman, Anthony;
Priestman, Miles;
Bertaux, Francois;
Martinez-Segura, Amalia;
Tang, Wenhao;
Whilding, Chad;
... Marguerat, Samuel; + view all
(2020)
Size-Dependent Increase in RNA Polymerase II Initiation Rates Mediates Gene Expression Scaling with Cell Size.
Current Biology
, 30
(7)
1217-1230.e7.
10.1016/j.cub.2020.01.053.
|
|
Tabernero, J;
Alsina, M;
Shitara, K;
Doi, T;
Dvorkin, M;
Mansoor, W;
Arkenau, H-T;
... Ilson, DH; + view all
(2020)
Health-related quality of life associated with trifluridine/tipiracil in heavily pretreated metastatic gastric cancer: results from TAGS.
Gastric Cancer
10.1007/s10120-020-01053-9.
|
|
|
Tabish, TA;
Hamblin, MR;
(2020)
Multivalent nanomedicines to treat COVID-19: A slow train coming.
Nano Today
, 35
, Article 100962. 10.1016/j.nantod.2020.100962.
|
|
Tabish, TA;
Narayan, RJ;
Edirisinghe, M;
(2020)
Rapid and label-free detection of COVID-19 using coherent anti-Stokes Raman scattering microscopy.
MRS Communications
, 10
(4)
pp. 566-572.
10.1557/mrc.2020.81.
|
|
Tan, WS;
Teo, CH;
Chan, D;
Ang, KM;
Heinrich, M;
Feber, A;
Sarpong, R;
... DETECT II trial collaborators, .; + view all
(2020)
Exploring patients’ experience and perception of being diagnosed with bladder cancer: A mixed methods approach.
BJU International
, 125
(5)
pp. 669-678.
10.1111/bju.15008.
|
|
|
Taylor, RM;
Fern, LA;
Barber, J;
Alvarez-Galvez, J;
Feltbower, R;
Lea, S;
Martins, A;
... Whelan, J; + view all
(2020)
Longitudinal cohort study of the impact of specialist cancer services for teenagers and young adults on quality of life: outcomes from the BRIGHTLIGHT study.
BMJ Open
, 10
(11)
, Article e038471. 10.1136/bmjopen-2020-038471.
|
|
|
Teachey, DT;
O'Connor, D;
(2020)
How I treat newly diagnosed T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma in children.
Blood
, 135
(3)
pp. 159-166.
10.1182/blood.2019001557.
|
|
Telfer, P;
De la Fuente, J;
Sohal, M;
Brown, R;
Eleftheriou, P;
Roy, N;
Piel, FB;
... Layton, DM; + view all
(2020)
Real-time national survey of COVID-19 in hemoglobinopathy and rare inherited anemia patients.
Haematologica
, 105
(11)
pp. 2651-2654.
10.3324/haematol.2020.259440.
|
|
|
Tempest, N;
Jansen, M;
Baker, A-M;
Hill, CJ;
Hale, M;
Magee, D;
Treanor, D;
... Hapangama, DK; + view all
(2020)
Histological 3D reconstruction and in vivo lineage tracing of the human endometrium.
Journal of Pathology
, 251
(4)
pp. 440-451.
10.1002/path.5478.
|
|
|
Terwisscha van Scheltinga, SEJ;
Wijnen, MHWA;
Martelli, H;
Rogers, T;
Mandeville, H;
Gaze, MN;
McHugh, K;
... Merks, HHM; + view all
(2020)
Local staging and treatment in extremity rhabdomyosarcoma. A report from the EpSSG-RMS2005 study.
Cancer Medicine
, 9
(20)
pp. 7580-7589.
10.1002/cam4.3365.
|
|
Teschendorff, AE;
Zhu, T;
Breeze, CE;
Beck, S;
(2020)
EPISCORE: cell type deconvolution of bulk tissue DNA methylomes from single-cell RNA-Seq data.
Genome Biology
, 21
, Article 221. 10.1186/s13059-020-02126-9.
|
|
|
The ICGC/TCGA Pan-Cancer Analysis of Whole Genomes Consortium;
(2020)
Pan-cancer analysis of whole genomes.
Nature
, 578
(7793)
pp. 82-93.
10.1038/s41586-020-1969-6.
|
|
|
The UK Coronavirus Cancer Monitoring Project team;
(2020)
The UK Coronavirus Cancer Monitoring Project: protecting patients with cancer in the era of COVID-19.
The Lancet Oncology
, 21
(5)
pp. 622-624.
10.1016/S1470-2045(20)30230-8.
|
|
Therond, C;
Lanceley, A;
Gibbon, S;
Rahman, B;
(2020)
The narrative paradox of the BRCA gene: An ethnographic study in the clinical encounters of ovarian cancer patients.
Anthropology & Medicine
, 27
(4)
pp. 449-464.
10.1080/13648470.2019.1663784.
|
|
Tjokrowidjaja, A;
Lee, CK;
Friedlander, M;
Gebski, V;
Gladieff, L;
Ledermann, J;
Penson, R;
... Pujade-Lauraine, E; + view all
(2020)
Concordance between CA-125 and RECIST progression in patients with germline BRCA-mutated platinum-sensitive relapsed ovarian cancer treated in the SOLO2 trial with olaparib as maintenance therapy after response to chemotherapy.
European Journal of Cancer
, 139
pp. 59-67.
10.1016/j.ejca.2020.08.021.
|
|
Turro, E;
Astle, WJ;
Megy, K;
Gräf, S;
Greene, D;
Shamardina, O;
Allen, HL;
... Ouwehand, WH; + view all
(2020)
Whole-genome sequencing of patients with rare diseases in a national health system.
Nature
, 583
pp. 96-102.
10.1038/s41586-020-2434-2.
|
|
Ulivi, L;
Kanber, B;
Prados, F;
Davagnanam, I;
Merwick, A;
Chan, E;
Williams, F;
... Werring, DJ; + view all
(2020)
White matter integrity correlates with cognition and disease severity in Fabry disease.
Brain
, 143
(11)
pp. 3331-3342.
10.1093/brain/awaa282.
|
|
Ulivi, L;
Squitieri, M;
Cohen, H;
Cowley, P;
Werring, DJ;
(2020)
Cerebral venous thrombosis: a practical guide.
Practical Neurology
, 20
(5)
pp. 356-367.
10.1136/practneurol-2019-002415.
|
|
van der Noll, R;
Jager, A;
Ang, JE;
Marchetti, S;
Mergui-Roelvink, MWJ;
de Bono, JS;
Lolkema, MP;
... Schellens, JHM; + view all
(2020)
Phase I study of intermittent olaparib capsule or tablet dosing in combination with carboplatin and paclitaxel (part 2).
Investigational New Drugs
, 38
pp. 1096-1107.
10.1007/s10637-019-00857-6.
|
|
van der Noll, R;
Jager, A;
Ang, JE;
Marchetti, S;
Mergui-Roelvink, MWJ;
Lolkema, MP;
de Jonge, MJA;
... Schellens, JHM; + view all
(2020)
Phase I study of continuous olaparib capsule dosing in combination with carboplatin and/or paclitaxel (Part 1).
Investigational New Drugs
, 38
pp. 1117-1128.
10.1007/s10637-019-00856-7.
|
|
van der Veen, SJ;
Vlietstra, WJ;
van Dussen, L;
van Kuilenburg, ABP;
Dijkgraaf, MGW;
Lenders, M;
Brand, E;
... Langeveld, M; + view all
(2020)
Predicting the Development of Anti-Drug Antibodies against Recombinant alpha-Galactosidase A in Male Patients with Classical Fabry Disease.
International Journal of Molecular Sciences
, 21
(16)
, Article 5784. 10.3390/ijms21165784.
|
|
|
Vijapurapu, R;
Baig, S;
Nordin, S;
Augusto, JB;
Price, AM;
Wheeldon, N;
Lewis, N;
... Steeds, RP; + view all
(2020)
Longitudinal Assessment of Cardiac Involvement in Fabry Disease Using Cardiovascular Magnetic Resonance Imaging.
JACC: Cardiovascular Imaging
, 13
(8)
pp. 1850-1852.
10.1016/j.jcmg.2020.03.004.
|
|
Vila Cuenca, M;
Marchi, G;
Barqué, A;
Esteban-Jurado, C;
Marchetto, A;
Giorgetti, A;
Chelban, V;
... Sanchez, M; + view all
(2020)
Genetic and Clinical Heterogeneity in Thirteen New Cases with Aceruloplasminemia. Atypical Anemia as a Clue for an Early Diagnosis.
International Journal of Molecular Sciences
, 21
(7)
, Article 2374. 10.3390/ijms21072374.
|
|
|
Villegas-Mendez, A;
Khandelwal, G;
McGowan, LM;
Dookie, RS;
Haley, MJ;
George, C;
Sims, D;
... Couper, KN; + view all
(2020)
Exhausted CD4⁺ T Cells during Malaria Exhibit Reduced mTORc1 Activity Correlated with Loss of T-bet Expression.
The Journal of Immunology
, 205
(6)
pp. 1608-1619.
10.4049/jimmunol.2000450.
|
|
von Karstedt, S;
Walczak, H;
(2020)
An unexpected turn of fortune: targeting TRAIL-Rs in KRAS-driven cancer.
Cell Death Discovery
, 6
, Article 14. 10.1038/s41420-020-0249-4.
|
|
|
Waddingham, W;
Nieuwenburg, SAV;
Carlson, S;
Rodriguez-Justo, M;
Spaander, M;
Kuipers, EJ;
Jansen, M;
... Banks, M; + view all
(2020)
Recent advances in the detection and management of early gastric cancer and its precursors.
Frontline Gastroenterology
10.1136/flgastro-2018-101089.
|
|
|
Walls, GM;
Oughton, JB;
Chalmers, AJ;
Brown, S;
Collinson, F;
Forster, MD;
Franks, KN;
... Greystoke, A; + view all
(2020)
CONCORDE: A phase I platform study of novel agents in combination with conventional radiotherapy in non-small-cell lung cancer.
Clinical and Translational Radiation Oncology
, 25
pp. 61-66.
10.1016/j.ctro.2020.09.006.
|
|
|
Wanner, C;
Feldt-Rasmussen, U;
Jovanovic, A;
Linhart, A;
Yang, M;
Ponce, E;
Brand, E;
... Ortiz, A; + view all
(2020)
Cardiomyopathy and kidney function in agalsidase beta-treated female Fabry patients: a pre-treatment vs. post-treatment analysis.
ESC Heart Failure
, 7
(3)
pp. 825-834.
10.1002/ehf2.12647.
|
|
|
Waterhouse, JV;
Hull, JH;
Linch, M;
(2020)
Corticosteroids for Urological Cancer Care During Coronavirus Disease 2019. Treat or Not to Treat?
European Urology
10.1016/j.eururo.2020.04.027.
(In press).
|
|
|
Watkins, TBK;
Lim, EL;
Petkovic, M;
Elizalde, S;
Birkbak, NJ;
Wilson, GA;
Moore, DA;
... Swanton, C; + view all
(2020)
Pervasive chromosomal instability and karyotype order in tumour evolution.
Nature
, 587
pp. 126-132.
10.1038/s41586-020-2698-6.
|
|
Werner, B;
Case, J;
Williams, MJ;
Chkhaidze, K;
Temko, D;
Fernández-Mateos, J;
Cresswell, GD;
... Sottoriva, A; + view all
(2020)
Measuring single cell divisions in human tissues from multi-region sequencing data.
Nature Communications
, 11
, Article 1035. 10.1038/s41467-020-14844-6.
|
|
|
Wilcz-Villega, E;
Carter, E;
Ironside, A;
Xu, R;
Mataloni, I;
Holdsworth, J;
Jones, W;
... Bianchi, K; + view all
(2020)
Macrophages induce malignant traits in mammary epithelium via IKKε/TBK1 kinases and the serine biosynthesis pathway.
EMBO Molecular Medicine
, Article e10491. 10.15252/emmm.201910491.
(In press).
|
|
|
Wilson, AJ;
Troy-Barnes, E;
Subhan, M;
Clark, F;
Gupta, R;
Fielding, AK;
Kottaridis, P;
... Khwaja, A; + view all
(2020)
Successful remission induction therapy with gilteritinib in a patient with de novo FLT3-mutated acute myeloid leukaemia and severe COVID-19.
[Letter].
British Journal of Haematology
, 190
(4)
e189-e191.
10.1111/bjh.16962.
|
|
Wong, S-L;
Alshaikhi, J;
Grimes, H;
Amos, RA;
Poynter, A;
Rompokos, V;
Gulliford, S;
... Mendes, R; + view all
(2020)
Retrospective Planning Study of Patients with Superior Sulcus Tumours Comparing Pencil Beam Scanning Protons to Volumetric-Modulated Arc Therapy.
Clinical Oncology
10.1016/j.clon.2020.07.016.
(In press).
|
|
|
Woodcock, HV;
Eley, JD;
Guillotin, D;
Platé, M;
Nanthakumar, CB;
Martufi, M;
Peace, S;
... Chambers, RC; + view all
(2020)
Author Correction: The mTORC1/4E-BP1 axis represents a critical signaling node during fibrogenesis.
[Corrigendum].
Nature Communications
, 11
, Article 4680. 10.1038/s41467-020-18621-3.
|
|
|
Wu, A;
Cremaschi, P;
Wetterskog, D;
Conteduca, V;
Franceschini, GM;
Kleftogiannis, D;
Jayaram, A;
... Attard, G; + view all
(2020)
Genome-wide plasma DNA methylation features of metastatic prostate cancer.
Journal of Clinical Investigation
, 130
(4)
pp. 1991-2000.
10.1172/JCI130887.
|
|
|
Wu, W;
Zhou, G;
Han, H;
Huang, X;
Jiang, H;
Mukai, S;
Kazlauskas, A;
... Lei, H; + view all
(2020)
PI3Kδ as a Novel Therapeutic Target in Pathological Angiogenesis.
Diabetes
, 69
(4)
pp. 739-748.
10.2337/db19-0713.
|
|
Xu, R;
Jones, W;
Wilcz-Villega, E;
Costa, AS;
Rajeeve, V;
Bentham, RB;
Bryson, K;
... Bianchi, K; + view all
(2020)
The breast cancer oncogene IKKε coordinates mitochondrial function and serine metabolism.
EMBO Reports
, Article e48260. 10.15252/embr.201948260.
|
|
|
Yanez-Guerra, LA;
Zhong, X;
Moghul, I;
Butts, T;
Zampronio, CG;
Jones, AM;
Mirabeau, O;
(2020)
Echinoderms provide missing link in the evolution of PrRP/sNPF-type neuropeptide signalling.
eLife
, 9
, Article e57640. 10.7554/eLife.57640.
|
|
|
Yip, HM;
Yong, K;
De-Silva, D;
Rabin, N;
(2020)
Assessing the safety of autologous stem cell transplant pathway via ambulatory care for patients with multiple myeloma.
Hematology/Oncology and Stem Cell Therapy
10.1016/j.hemonc.2020.01.001.
(In press).
|
|
|
Yoshida, K;
Gowers, KHC;
Lee-Six, H;
Chandrasekharan, DP;
Coorens, T;
Maughan, EF;
Beal, K;
... Campbell, PJ; + view all
(2020)
Tobacco smoking and somatic mutations in human bronchial epithelium.
Nature
, 578
pp. 266-272.
10.1038/s41586-020-1961-1.
|
|
Younger, E;
Smrke, A;
Lidington, E;
Farag, S;
Ingley, K;
Chopra, N;
Maleddu, A;
... Jones, RL; + view all
(2020)
Health-Related Quality of Life and Experiences of Sarcoma Patients during the COVID-19 Pandemic.
Cancers
, 12
(8)
, Article 2288. 10.3390/cancers12082288.
|
|
|
Zakeri, K;
Rotolo, F;
Lacas, B;
Vitzthum, LK;
Le, Q-T;
Gregoire, V;
Overgaard, J;
... MARCH/MACH-NC Collaborative Group and the Head and Neck Cancer I; + view all
(2020)
Predictive classifier for intensive treatment of head and neck cancer.
Cancer
, 126
(24)
pp. 5263-5273.
10.1002/cncr.33212.
|
|
Zhai, H;
Moore, D;
Jamal-Hanjani, M;
(2020)
Inactivation of RB1 and histological transformation in EGFR-mutant lung adenocarcinoma.
Annals of Oncology
, 31
(2)
pp. 169-170.
10.1016/j.annonc.2019.12.004.
|
|
Znati, S;
Carter, R;
Vasquez, M;
Westhorpe, A;
Shahbakhti, H;
Prince, J;
Vlckova, P;
... Sharma, RA; + view all
(2020)
Radiosensitisation of Hepatocellular Carcinoma Cells by Vandetanib.
Cancers
, 12
(7)
, Article 1878. 10.3390/cancers12071878.
|
|
Zuily, S;
Cohen, H;
Isenberg, D;
Woller, SC;
Crowther, M;
Dufrost, V;
Wahl, D;
... Devreese, KMJ; + view all
(2020)
Use of direct oral anticoagulants in patients with thrombotic antiphospholipid syndrome: Guidance from the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis.
J Thromb Haemost
, 18
(9)
pp. 2126-2137.
10.1111/jth.14935.
|
|
Zuily, S;
Clerc-Urmes, I;
Bauman, C;
Andrade, D;
Sciascia, S;
Pengo, V;
Tektonidou, MG;
... Erkan, D; + view all
(2020)
Cluster analysis for the identification of clinical phenotypes among antiphospholipid antibody-positive patients from the APS ACTION Registry.
Lupus
, 29
(11)
pp. 1353-1363.
10.1177/0961203320940776.
|
|
|
Zwi-Dantsis, L;
Winter, CW;
Kauscher, U;
Ferrini, A;
Wang, B;
Whittaker, TE;
Hood, SR;
... Stevens, MM; + view all
(2020)
Highly purified extracellular vesicles from human cardiomyocytes demonstrate preferential uptake by human endothelial cells.
Nanoscale
10.1039/d0nr04278a.
(In press).
|
|
Working / discussion paper
|
Borrello, T;
Tam, CH;
Shafat, M;
Rushworth, S;
Bowles, K;
Bailey, S;
Crabb, S;
... Douglas, L; + view all
(2020)
Synthesis of Carboxamides Tranylcypromine Analogues as LSD1 (KDM1A) Inhibitors for AML.
ChemRxiv: Cambridge, UK.
|
|
Lam, SD;
Bordin, N;
Waman, VP;
Scholes, HM;
Ashford, P;
Sen, N;
van Dorp, L;
... Orengo, CA; + view all
(2020)
SARS-CoV-2 spike protein predicted to form complexes with host receptor protein orthologues from a broad range of mammals.
BioRxiv: Cold Spring Harbor, NY, USA.
|
|
Laszlo, HE;
Seward, E;
Ayling, R;
Lake, J;
Malhi, A;
Hackshaw, A;
Stephens, C;
... Machesney, M; + view all
(2020)
Quantitative faecal immunochemical test for patients with 'high risk' bowel symptoms: a prospective cohort study.
MedRxiv: Cold Spring Harbor, NY, USA.
|
|
Lujan, Celia;
Tyler, Eleanor;
Ecker, Simone;
Webster, Amy;
Stead, Eleanor;
Martinez Miguel, Victoria;
Milligan, Deborah;
... Bjedov, Ivana; + view all
(2020)
A CellAgeClock for expedited discovery of anti-ageing compounds.
bioRxiv: Cold Spring Harbor, NY, USA.
|
|
|
Tran, J;
Gunther, O;
Sherwood, K;
Fenninger, F;
Allan, L;
Lan, J;
Sapir-Pichhadze, R;
... Keown, P; + view all
(2020)
Population Frequencies Determined by Next-generation Sequencing Provide Strategies for Prospective HLA Epitope Matching for Transplantation.
Research Square: Durham, NC, USA.
|
Conference item
|
Kotsiou, E;
Hou, TZ;
Robinson, J;
Varsani, S;
Oakes, T;
Becker, PD;
Patel, S;
... Newton, K; + view all
(2020)
Next generation clonal neoantigen targeting T cells, generated using the PELEUS (TM) bioinformatics platform and the VELOS (TM) manufacturing method show superior reactivity and phenotypic characteristics than classical TIL products.
Presented at: AACR Annual Meeting, Philadelphia, PA, USA.
|
Thesis
|
Al Bakir, Maise;
(2020)
The Evolution of Metastases in Non-Small Cell Lung Cancer.
Doctoral thesis (Ph.D), UCL (University College London).
|
|
Al Belushi, Hind;
(2020)
Development and characterisation of MSC-seeded decellularised airway scaffolds for regenerative bioengineering.
Doctoral thesis (Ph.D), UCL (University College London).
|
|
Alrasheed, Nouf;
(2020)
Characterisation of the immune cell content of bone marrow from patients with multiple myeloma.
Doctoral thesis (Ph.D), UCL (University College London).
|
|
Alrifai, Doraid;
(2020)
Enhancing the effect of Tumour necrosis factor - Related Apoptosis Inducing Ligand (TRAIL) in malignant pleural mesothelioma.
Doctoral thesis (Ph.D), UCL (University College London).
|
|
Aref, Sarah;
(2020)
Characterizing the Mechanisms Underlying Measles Virus Mediated Oncolysis in a Stromal Model of Cellular Transformation.
Doctoral thesis (Ph.D), UCL (University College London).
|
|
|
Areso Zubiaur, Itziar Ibone;
(2020)
Pro-apoptotic TRAIL- and CDK9 inhibition-based cancer therapy.
Doctoral thesis (Ph.D), UCL (University College London).
|
|
Bultitude, Will P.;
(2020)
Generating full-length Killer-cell Immunoglobulin-like Receptor (KIR) gene sequences using Third Generation long-amplicon sequencing to assess the impact of KIR polymorphism on Haematopoietic Cell Transplantation outcomes.
Doctoral thesis (Ph.D), UCL (University College London).
|
|
Burt, Richard James;
(2020)
Defining the role of mesenchymal stromal cells in treatment resistance in acute lymphoblastic leukaemia.
Doctoral thesis (Ph.D), UCL (University College London).
|
|
|
Corbett, Simon Edward;
(2020)
Understanding the mechanisms of action of pyrrolobenzodiazepine dimer-based antibody-drug conjugates.
Doctoral thesis (Ph.D), UCL (University College London).
|
|
Evans, Pamela;
(2020)
The Effect of Acute Graft-Versus-Host Disease upon the Peripheral T cell Niche.
Doctoral thesis (Ph.D), UCL (University College London).
|
|
|
Fittall, Matthew;
(2020)
Exploring tumour evolution through mutational patterns in bone tumours.
Doctoral thesis (Ph.D), UCL (University College London).
|
|
Galazi, Myria;
(2020)
‘ErbB activation and heterodimerisation is responsible for resistance upon PI3K-mTOR inhibition in metastatic prostate cancer’.
Doctoral thesis (Ph.D), UCL (University College London).
|
|
|
Greenwood, Hannah E.;
(2020)
Prediction of Drug Resistance in Preclinical Models of Cancer with System xc- Specific Positron Emission Tomography Radiotracers.
Doctoral thesis (Ph.D), UCL (University College London).
|
|
Harrasser, Micaela;
(2020)
ROR1-targeted adoptive immunotherapies.
Doctoral thesis (Ph.D), UCL (University College London).
|
|
Hockings, Catherine Ann;
(2020)
Secondary driver mutations in CEBPA-mutated Acute Myeloid Leukaemia.
Doctoral thesis (Ph.D), UCL (University College London).
|
|
|
Jones, Morgan Llewellyn;
(2020)
Structural and functional analysis of the human XPF-ERCC1 DNA repair endonuclease.
Doctoral thesis (Ph.D), UCL (University College London).
|
|
Laycock, Emma Victoria;
(2020)
Modelling first-hit functions of the t(12;21) ETV6-RUNX1 translocation in pluripotent stem cells.
Doctoral thesis (Ph.D), UCL (University College London).
|
|
Przewrocka, Joanna Paula;
(2020)
Functions of ZNF516 in embryonic development, health, and disease.
Doctoral thesis (Ph.D), UCL (University College London).
|
|
Rebollo Gomez, Elena;
(2020)
New approaches to modulate VPS34 PI 3-kinase activity.
Doctoral thesis (Ph.D), UCL (University College London).
|
|
Simpson Ragdale, Holly;
(2020)
p53 restricts injury-induced plasticity in cortical astrocytes.
Doctoral thesis (Ph.D), UCL (University College London).
|
|
Solomon, Isabelle;
(2020)
Targeting regulatory T cells for therapeutic gain in cancer therapy.
Doctoral thesis (Ph.D), UCL (University College London).
|
|
Sun, Yuxin;
(2020)
Identification of antigen-specific patterns from high-dimensional sequencing data.
Doctoral thesis (Ph.D), UCL (University College London).
|
|
|
Tavares Cornejo, Manuel de Jesus;
(2020)
Disregulation of PRC2 function caused by the JAZF1-SUZ12 fusion protein.
Doctoral thesis (Ph.D), UCL (University College London).
|
|
Taylor, Alice;
(2020)
The VWF-ADAMTS13 axis and related haematological aspects of acute ischaemic brain injury.
Doctoral thesis (M.D(Res)), UCL (University College London).
|
|
|
Watkins, Thomas Benjamin Kingdon;
(2020)
The role of chromosomal instability and parallel evolution in cancer.
Doctoral thesis (Ph.D), UCL (University College London).
|
